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ABSTRACT 
 
 Hypoxia is a potent immunomodulatory condition that underlies a wide array of disease 
states and associated comorbidities. Inflammation appears to be a critical factor in the adverse 
psychological outcomes linked with hypoxia/reoxygenation injury. A causative role for brain-
based IL-1 has been suggested in hypoxia-induced cognitive impairment and anxiety-like 
behaviors. However, the exact mechanism responsible has yet to be fully understood. Therefore, 
in this study we examined the impact of acute hypoxia on hippocampal-independent memory 
recall and particular cellular localization of inflammasome activity within the amygdala. Mice 
were exposed to hypoxic (6% oxygen/94% nitrogen) or normoxic (ambient) conditions for a 
period of 2 hours. Following 2 hours of reoxygenation, mice showed 65% increased caspase-1 
activity in the amygdala by ICV-IHC determination with no significant changes observed within 
the hippocampus. To determine the extent of inflammasome activation in hypoxia/reoxygenation 
injury, drugs targeting potential activators such as K+ efflux and A2A adenosine receptor were 
administered. After glyburide (K+ efflux antagonist) and 3,7-dimethyl-1-prop-2-ynyl-purine-2,6-
dione (DMPX-A2A adenosine receptor antagonist) administration, both drugs significantly 
reduced the level of caspase-1 activation in the amygdala correlating with the restoration of 
performance on the novel object recognition memory (NOR) task and thus mitigating hypoxia-
induced retrograde amnesia. To determine the cellular localization of caspase-1 activation within 
the amygdala, a dual stain protocol was developed and showed that hypoxia induced 
significantly greater co-localization of caspase-1 and neurons. This result demonstrates the 
contribution of neuronal cells to the increased activation of caspase-1 following 
hypoxia/reoxygenation. Interestingly, IGF-I neuron-specific knockout mice showed similarly 
reduced caspase-1 activation in the amygdala and correction of NOR performance. In addition, 
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hypoxia/reoxygenation significantly increased serine phosphorylation of insulin-receptor 
substrate 1 (IRS-1) and p70 S6 Kinase (p70SK) in whole brain. However, no change in IGF-I, 
protein kinase A (PKA), or cyclic AMP (cAMP) was observed in either the amygdala or 
hippocampus. These results suggest that hypoxia-induced retrograde amnesia is dependent on 
caspase-1 activation in the amygdala via a neuronal K+ efflux, A2A adenosine receptor, and 
IGF-I associated mechanism. 
 Next, we examined a real-life scenario in which hypoxic conditions have been observed 
such as that displayed in obesity or following chronic high-fat diet (HFD) intake. In this study, 
mice were fed a HFD from weaning for 1, 3 or 6 weeks. Similar to hypoxia, mice displayed 
impaired NOR performance after 1 and 3 weeks of HFD consumption when compared to low-fat 
diet (LFD) controls but surprisingly recovered performance after 6 weeks of diet. In a 
hippocampal-dependent task, object location recognition (OLR), HFD consumption did not 
impair cognition until 3 and 6 weeks of diet. Additionally, mice displayed anxiety-like behaviors 
by measure of both the open-field and elevated zero maze tests following 3 weeks of HFD intake 
but remained comparable to LFD controls at 1 and 6 weeks of diet. These HFD-associated 3 
week impairments correlated with the suppression of glutathione (GSH):glutathione disulfide 
(GSSG) increase in both the amygdala and hippocampus. Glyburide, a second generation 
sulfonylurea used for type 2 diabetes and K+ efflux antagonism, restored HFD-induced NOR 
impairment and alleviated anxiety-like behaviors in mice fed HFD for 3 weeks following a single 
dose. In addition, glyburide administration increased the HFD GSH:GSSG ratio within the 
amygdala but not the hippocampus. These findings suggest that obesity-associated childhood 
cognitive and psychopathologies can be corrected by targeting the blocking ATP-sensitive K+ 
channels with drugs such as glyburide. 
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 Finally, we looked to investigate another real-life scenario that places firefighters and 
first responders at risk for both the acute- and long-term due to hypoxic exposure during various 
firefighting activities. A rising concern amongst this group is increased cancer incidence 
associated with carcinogen and asphyxiate contact during firefighting. Therefore, in order to 
investigate the increased disease risk associated with smoke inhalation, mice were placed in 
overhaul, the period following suppression where knockdown of fire-materials occurs, after a 
live-fire scenario for 15 minutes following an interior or transitional tactical choice. Lung tissue 
was then harvested 2 hours post-overhaul for RNA-seq analysis. The transitional tactical choice 
reduced environmental significantly by a 10.3% reduction in average temperature when 
compared to the interior attack. This result correlated with a marked reduction in the number of 
significantly differentially expressed genes in the transitional tactical choice compared to the 
interior. Interestingly, interior attack resulted in up-regulation of a number of carcinogenic genes 
corresponding with down-regulation of numerous immunomodulatory genes. Disease pathways 
signaling through rap1 signaling, natural killer cell mediated cytotoxicity, and asthma were over-
represented within the interior tactic. These results indicate that overhaul exposure after an 
interior tactical choice show immunosuppression with the advancement of cancer-associated 
genes whereas the transitional choice mitigates these risks. In conclusion, hypoxia/reoxygenation 
classically induces retrograde amnesia via increased neuronal-derived caspase-1 through K+ 
efflux, A2A adenosine receptor, and IGF-I activity. But real-life scenarios of hypoxia, including 
a high-fat challenge and smoke inhalation, subsequently induce memory impairment, anxiety-
like behaviors, and cancer risk via non-canonical caspase-1 independent pathways.  
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CHAPTER 1: LITERATURE REVIEW 
Summary 
Hypoxia manifests in a myriad of clinical and sub-clinical comorbidities as a main 
contributor to the observed conditions as well as a byproduct. The loss of oxygen, even relatively 
low levels of oxygen desaturation, has the capacity to promote variable levels of disease states. 
Several studies have determined the explicit mechanisms underlying these various diseases 
typically by hypoxia inducing pathological pathways via tissue damage, reperfusion, cellular 
damage, oxidative stress and inflammation. However, these pathways are not always associated 
with the loss of oxygen and heavily depend on the level as well as duration of hypoxemia or 
period of reoxygenation. Therefore, this review will expand upon then demonstrate the 
mechanisms and maladies associated with hypoxia, especially following reoxygenation, and the 
ability for hypoxia to act both systemically and centrally to propagate and sustain various disease 
conditions. Additionally, review of existing and understood mechanisms allows for narrowing 
future novel study directions and especially development of new therapies.  
Introduction 
 The loss of oxygen in any tissue has a significant impact on the immediate tissues 
impacted as well as additional tissues through peripheral and central pathways. Hypoxia is a 
serious contributor to various pathophysiology cases and morbidity, in up to twenty percent of 
autopsies reported some amount of hypoxia-induced pathological morphology was apparent, 
which are especially apparent in the central nervous system (CNS) under these conditions 
(Oechmichen and Meissner 2006). Hypoxia results when tissues are subjected to a reduced or 
inadequate supply of oxygen to the respective tissue, with neuronal tissues being the primary 
target of hypoxia in the CNS (Mukandala et al. 2016). It is important to recognize however that 
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hypoxia increases cerebral blood flow and has largely reversible effects following times of 
respiratory stress (asthma, COPD, etc.) (Oechmichen and Meissner 2006), through transient 
hypoxic experiences such as high altitude (Sarkar et al. 2003), or obstructive sleep apnea 
(Yarlagadda et al. 2008). Whereas, these experiences and relative impact are similar in nature to 
ischemic responses, conversely, ischemic conditions result from the reduction or often the stop in 
blood flow entirely to the target tissues. Thus, the lack of oxygen to the necessary tissues is 
associated with significant greater tissue damage and often irreversible destruction of cells (e.g. 
necrosis), especially within neurons (Auer 2000). The primary and secondary injury following 
tissue hypoxemia is accompanied by the necessary requirement of reoxygenation in order to 
mitigate and recover from hypoxic as well as ischemic conditions (Fu et al. 2006; Schurr et al. 
1997). Reoxygenation is essential but with this recovery comes negative side-effects including 
increased cell death (Saikumar et al. 1998) and inflammation (Eltzschig and Carmeliet 2011) 
displaying an important duality in the recovery from hypoxia. Therefore, hypoxia and associated 
reoxygenation are important conditions to comprehend as the loss of oxygen critically impacts 
various vital tissues such as the brain. 
 
 Traditionally, hypoxia is often mediated by hypoxia inducible factors (HIF), including 
HIF-1α and HIF-1β. These important factors dedicated to oxygen sensing in the body are 
universally expressed and activate via an oxygen-dependent manner. Under normoxic conditions, 
HIF-1α is regularly degraded due to hydroxylation by prolyl hydroxyl domains (PHDs) (Moroz 
et al. 2009). However, during low-oxygen (hypoxic) conditions the PHD capacity to bind to HIF-
1α is inhibited resulting in an increase in constitutive protein expression. The increased 
expression allows for the recruitment of various transcriptional co-activators and hypoxia-related 
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proteins through binding of the hypoxic responsive element (HRE) (Mukandala et al. 2006). 
Binding of HRE prompts genes, such as vascular endothelial growth factor (VEGF) and insulin 
growth factor (IGF), important for recovery and often act in a neuroprotective capacity by 
increasing oxygen delivery and decreasing oxygen consumption in affected tissues (Semenza 
2014).  
 
In addition to hypoxia inducible-factors, hypoxic conditions can activate various 
inflammatory pathways stimulating production of traditional inflammatory markers (Eltzschig 
and Carmeliet 2011). Basic increases in altitude have been shown to increase serum levels of IL-
6, IL-6R, IL-1RA, and C-reactive protein (Hartmann et al. 2000). Also, greater injury following 
hypoxic events correlated with increased toll-like receptor (TLR) 4, an innate immune receptor 
for bacterial lipopolysaccharide (Krűger et al. 2009), which demonstrates the connection 
between hypoxia and classical inflammation. Interestingly, tissues and cells alone can create 
environments of severe hypoxia, such as inflamed intestine inducing increased levels of both 
hypoxia-inducible factors (Giatromanolaki et al. 2003). More recently, studies have 
demonstrated the importance of tissue hypoxia in multiple cancers and how effective treatments 
of cancer often address the hypoxic phenotype and concomitant symptoms such as inflammation 
(Vaupel and Mayer 2007). Hypoxia/reoxygenation is a significant contributor to a variety of 
comorbidities and the understanding of these traditional oxygen-sensing mechanisms and their 
respective pathological pathways is important for future treatment options. Though, canonical 
pathways contribute heavily to our current understanding, non-traditional pathways that are less 
understood could lead to more efficacious treatment as described in the following sections. 
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A role for caspase-1 and IL-1 
Interleukins (IL) are important cytokines crucial to the immune response, both innate and 
adaptive, with greater than 40 discovered to date (Akdis et al. 2011). The IL-1 family features 11 
ligands including important contributors to local and systemic inflammation, such as IL-1β, and 
genes that protect against these immune responses in the form of IL-1RA amongst others 
(Dinarello 2009). IL-1β has been shown previously to mediate a number of peripheral disease 
conditions including diabetes (Dinarello et al. 2010) and additional autoinflammatory diseases 
(Goldbach-Mansky 2012). More importantly, recent studies have determined a role for IL-1β in 
significantly impairing various centrally-mediated tasks such as cognitive and executive 
functioning (Dantzer et al. 2008; Simen et al. 2011), as well as possible susceptibility to 
Parkinson’s disease (Koprich et al. 2008). 
 
Importantly, the relatively recent discovery of the protein complexes capable of 
processing these various interleukins in response to an immune challenge led to advances in the 
understanding of the innate immune response. These complexes include the multi-protein 
containing inflammasomes (Martinon et al. 2002) which activate and form in order to process 
cysteine-dependent protease caspase-1 within the cell (Cerretti et al. 1992). Inflammasomes 
consist of a nucleotide-binding domain leucine-rich repeat-containing receptors (NLRs), often an 
adaptor protein such as an apoptosis-associated speck-like protein containing a CARD domain 
(ASC), and the cysteine protease procaspase-1 resulting in the autocatalysis and eventual 
activation of active-caspase-1 (Martinon et al. 2002). Primarily, once enzymatically active, 
caspase-1 action is to process the cytokines pro-IL-1β and pro-IL-18 to their mature form 
(Thornberry et al. 1992). These are markedly proinflammatory cytokines resulting in recruitment 
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of innate immune cells and subsequent adaptive immune response (Dinarello 2009). In 
particular, the NLRP3 inflammasome is the most investigated and subsequently most well-
known of the 22 human inflammasomes (Sutterwala et al. 2014). Throughout these 
investigations it was determined that NLRP3 can be activated in numerous ways such as 
pathogens, pore-forming toxins, environmental irritants, and endogenous damage-associated 
molecular patterns through a two-step model of priming and activation. Following priming, more 
specifically activation of NLRP3 is mediated by crystalline molecules such as silica and 
asbestos, adenosine triphosphate (ATP), nigericin, endoplasmic reticulum stress, mitochondrial 
dysfunction, and the requirement of ion fluxes including that of potassium efflux. Analysis of the 
NLRP3 inflammasome displays the important role in the activation of various pro-inflammatory 
cytokines to modify both the innate and adaptive immune responses. However, the unregulated 
expression of this complex can result in abnormal behaviors and contribute to various disease 
conditions. 
 
Interestingly, several studies have been able to show the impact of hypoxia inducing 
numerous NLRP3 activating metabolites and conditions for inflammasome activation. These 
studies include hypoxia modulating ATP release (Orriss et al. 2009) with supplementary studies 
demonstrating an increase in the concentration of adenosine (Hagberg et al. 1987). Additionally, 
hypoxia has been shown to precipitate endoplasmic reticulum stress (Bi et al. 2005) and 
mitochondrial dysfunction (Weinberg et al. 1999). Hypoxic conditions have been shown recently 
to up-regulate NLRP3 directly (Ystgaard et al. 2015; Iyer et al. 2009). Hypoxia is an important 
immunomodulatory condition impacting directly or indirectly the activation of NLRP3. 
Therefore, understanding the actions of this dynamic is necessary for complete understanding.  
6 
 
Hypoxia and Disease 
 As previously stated, studies have demonstrated the role of hypoxia in progressing, 
contributing, and exacerbating the pathogenesis and resulting abnormal behaviors surrounding a 
number of disease states. These conditions often represent a duality in their respective actions 
regarding hypoxia, whereas a number of studies characterize hypoxia as a contributor to the 
underlying cause of the disease, many additional studies have displayed the ability for conditions 
to induce hypoxic environments ultimately resulting in intensification and worsening of the 
disease. Examples of these conditions will be discussed in the following paragraphs. 
 
 Hypoxia and reoxygenation play an important role in the cause or increased risk of 
multiple diseases or aberrant behaviors. An important contributor in many diseases is increased 
inflammation which can lead to increased progression or pathogenesis. Hypoxia, as described 
previously, can induce inflammation via canonical and non-canonical pathways. The traditional 
pathways include the increase in IL-6, IL-6R, C-reactive protein, TNF-alpha and TLR-4 
following hypoxic exposure (Hartmann et al. 2000; Kruger et al. 2009; Tam et al. 2007). 
Furthermore, these increases in inflammation is often associated with increased comorbidities 
such as inflammatory bowel disease (Colgan and Elzzschig 2012), pulmonary disease 
(Minamino et al. 2001), and cardiovascular disease (Garvey et al. 2009). Another important 
consequence of hypoxia is cognitive impairment (Asmaro et al. 2013). Hypoxia can influence 
cognition in a variety of ways including both peripheral (Santo-Yamada et al. 2001) and central 
action (Van Der Post et al. 2002). Hypoxia has been shown to largely impact spatial memory 
(Shukitt-Hale et al. 1994), especially through mechanisms of neural attack (Almli et al. 2000), 
inflammation including cyclooxygenase-2 activation (Li et al. 2003), and dendritic/monoamine 
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modification (Kheirandish et al. 2005) amongst other important pathways. In addition, 
hypoxia/reoxygenation demonstrates a critical role in both anterograde (Chiu et al. 2012) and 
retrograde amnesia (Udayabanu et al. 2008).  
 
Alzheimer’s disease (AD) is an increasingly important condition for study as the 
underlying pathogenesis is still unknown yet AD impacts a significant number of the population, 
especially amongst the elderly (Hebert et al. 2003). Recently, hypoxia has been shown to provide 
vital information for the underlying causes of AD, with Sun et al presenting evidence that 
hypoxia up-regulates β-secretase cleavage of APP and amyloid-β protein production by 
increasing the relative enzyme BACE1 facilitating AD pathogenesis. However, several studies 
have shown the importance of HIF-1α mediated neuroprotection of neurons from AD pathology 
(Chavez and LaManna 2003) and reduced levels are typically observed in AD brains (Liu et al. 
2008). Therefore, hypoxia plays an important dual role in the body’s immune response by 
mediating the insult but often these downstream pathways come with unintended consequences.  
 
Another hypoxia-related injury that impacts a significant number of the population is 
cardiovascular injury and disease (Somers et al. 2008; Semenza 2013). More specifically, 
incidence of cardiovascular disease amongst firefighters over the past decades whilst deaths 
during work have been steadily decreasing (Soteriades et al. 2011). There have been several 
explanations surrounding this phenomena, for example shift work (Soteriades et al. 2011) or 
noise (Burgess et al. 2001), but one of the more significant modifiers of disease appears to be the 
exposure to hazardous environmental conditions resulting in tissue hypoxia (Kales et al. 2009). 
Even though exposure during the fire attack and suppression phases have drastically been 
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reduced with the mandated use of self-contained breathing apparatuses, these mitigation units are 
not often worn during overhaul which leaves first responders at risk of hypoxia and subsequent 
disease pathology (Burgess et al. 2001). The smoke inhalation leading to tissue hypoxia 
consequently increases endothelial dysfunction, heart rate, blood pressure, blood coagulability, 
arrhythmia and atherosclerosis (Smith et al. 2013; Dockery 2001). These symptoms are typical 
of a canonical response associated with hypoxia as referenced earlier. Recent studies have in 
addition emphasized the analogous rising pattern of cancer incidence among these individuals 
(Daniels et al. 2013). The exact mechanisms underlying these recent studies is still unknown. 
Many have posited a likely cause similar to that of cardiovascular disease with that of apparent 
tissue hypoxia following smoke inhalation. This seems probable considering malignant 
mesothelioma and respiratory cancers are significantly represented amongst cohorts of 
firefighters (Daniels et al. 2013). However, classically, hypoxia has been revealed to influence 
cardiovascular disease through induction of nitric oxide/oxidative stress (Manukhina et al. 2006; 
Giordano 2005) as well as increasing HIF-1 to induce atherosclerosis (Savransky et al. 2006). 
These studies indicate the ability for hypoxia alone to promote and induce a vast array of 
diseases and their associated comorbidities. Therefore, fully understanding how to treat or 
modify hypoxia-inducible pathways is an important step in addressing the underlying causes of 
these important diseases. 
 
Hypoxic conditions within cells can be of equal or in some cases a greater consequence 
to human health. These various conditions include sleep apnea (Ryan et al. 2005), 
lipopolysaccharide (LPS) (Mi et al. 2008), obesity (Hosogai et al. 2007), and cancer/tumor 
progression (Brown and Wilson 2004). With regard to sleep apnea, the intermittent hypoxia that 
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occurs during interrupted sleep can result in desaturation of oxygen causing profound hypoxemic 
conditions (Remmers et al. 1978). The associated hypoxemic state can then impact secondary 
factors such as cognition (Findley et al. 1986) via various associated inflammatory pathways 
including increased C-reactive protein (Shamsuzzan et al. 2002). Similarly, lipopolysaccharide 
(LPS), a potent immunomodulatory endotoxin capable of producing a traditional inflammatory 
reaction by activating the innate immune response (Ulich et al. 1993), has the ability to create 
hypoxic conditions within cells by increasing HIF-1α in the development of LPS-induced 
symptoms (Peyssonnaux et al. 2007) with secondary effects being sepsis and sickness behaviors 
(Dantzer et al. 2008).  
 
Another example of hypoxic conditions within cells exerting secondary effects causing 
significant impacts on human health is the role obesity or a high-fat diet challenge plays in 
subjugating the body to hypoxemia. Recently, high-fat diets contributing to the overall obese 
phenotype have been shown in multiple studies to contribute to adipose tissue hypoxia (Hosogai 
et al. 2007; Ye 2009) and subsequent metabolic dysregulation. The subsequent dysregulation has 
the ability to produce chronic inflammation, leptin elevation, and inflammasome activators such 
as endoplasmic reticulum stress and mitochondrial dysfunction (Ye 2009). One of the more 
recent advances in hypoxia understanding is the role it plays in both tumor and cancer 
progression. Solid tumors have been shown to contain regions of significantly hypoxemic 
concentrations which results from the imbalance of energy metabolism associated with increased 
cell proliferation (Airley et al. 2000). These regions often are surrounded by necrotic regions that 
produce inflammation, including HIF-1, as well as increasing genes associated with cancer 
progression (Brown and Wilson 2004). Therefore, these studies highlight the important 
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contribution that cellular hypoxia has on both the primary but more notably the secondary 
effects. Ultimately, developing strategies that target hypoxia both directly and indirectly will be 
important in improving human health amongst the public.  
Adenosine and Disease 
 Adenosine is an important neuroimmune bioactive modulatory agent that acts amongst 
both the periphery and the central nervous system (CNS). Its associated receptors have long been 
related with acting in a neuroprotective role by decreasing glutamate release and 
hyperpolarization of neurons following neuronal injury (Cunha 2005). But more recently, studies 
have challenged this idea and instead show adenosine and its’ receptors actually propagate and 
stimulate neurodegeneration (Chiu et al. 2012; Chiu et al. 2014; Latini et al. 1999). These actions 
are difficult to unravel as endogenous adenosine is a purine nucleoside working through multiple 
G protein-coupled receptors in the form of A1, A2A, A2B, and A3 receptors (Fredholm et al. 
1994). The A2A and A2B receptors have the ability to activate intracellular cAMP whereas 
inhibition occurs with binding to A1 and A3. Most importantly, the A2A adenosine receptor 
agonism induces a cAMP increase, therefore upregulating protein kinase A (PKA) resulting in 
the opening of ATP-sensitive potassium channels (Kleppisch and Nelson 1995) decreasing 
activity in neurons (Fujimura et al. 1997). Whereas the A1 adenosine receptor, typically 
associated with neuroprotection (Dulla and Masino 2013), inhibits cAMP and downstream 
adenylyl cyclase (Rebola et al. 2005). These various adenosine signaling pathways have 
significant consequences in times of distress and disease with therapeutic targeting of these 
receptors being of recent interest. 
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 Of late, the ability for adenosine to act as a danger signal has been of particular interest. It 
is not surprising that adenosine could be an important danger signal activating innate immune 
complexes such as inflammasomes, since adenosine is a metabolic intermediate of ATP 
metabolism (Chiu et al. 2014) and ATP has long been shown to activate the NLRP3 
inflammasome, as stated previously. Additionally, adenosine is greatly increased following 
metabolic stress and inflammation (Hagberg et al. 1987) which are similar activators of HIF-1α 
as described above. In support of this notion, Chiu et al. 2014 showed that adenosine 
injection/perfusion increased both caspase-1 and IL-1β which results in memory impairment 
(Chiu et al. 2012) and anxiety-like behaviors. Adenosine has also been associated with a variety 
of abnormal behaviors such as depression-like symptoms, fatigue, and irritability (Juliano and 
Griffiths 2004). These symptoms and response of adenosine administration in both the periphery 
and central nervous system act similarly to hypoxia-induced factors. More so, further 
understanding of adenosine action, especially the separation of neuroprotective and 
neurodegenerative impact, is important in promoting efficacious treatments for a variety of 
impaired behaviors. 
IGF-1 Signaling and Disease 
 Insulin-growth factor-1 (IGF-I) is a substantial mediator of a variety of signaling 
cascades within the cell which significantly contribute to cell proliferation, modulation of tissue 
differentiation, and protection from apoptosis (Laviola et al. 2007). IGF-I is a pleiotropic growth 
hormone that has its highest concentration of serum production in the liver (Yakar et al. 1999) 
but in addition can cross the blood-brain barrier or be produced locally in the CNS in times of 
distress or injury (O’Donnel et al. 2002). Both the availability and action of IGF-I is determined 
by the respective binding protein (BP) with six distinct IGFBPs to exert a variety of different 
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biological functions (Underwood et al. 1994). In addition, IGF-I typically activates the tyrosine 
kinase receptor IGF-1R and can promote signaling of HIF-1α and HIF-2α (Fukuda et al. 2002) 
through the phosphatidylinositol-3-kinase (PI3K) or mitogen-activated protein kinase (MAPK) 
cascading pathways (Russo et al. 2005). These important pathways once activated regulate cell 
homeostasis, stress resistance and anti-apoptotic but IGF-I is especially crucial during 
development based on the ability to control both cell cycling and proliferation (Dupont and 
Holzenberger 2003). The activation of these ubiquitous pathways allows for IGF-I to represent 
various roles in disease that can be both protective and harmful depending on the insult or injury. 
 
 Several studies have identified IGF-I as playing a crucial protective role in a variety of 
diseases including hypoxia-ischemia (Guan et al. 2003), neurodegenerative disease (Doré et al. 
1997), and possibly Alzheimer’s/Parkinson’s disease (Wei et al. 2002; Ebert et al. 2008). Guan et 
al deduced that central IGF-I administration reduces infarct size in the brain following ischemic 
injury. These findings were similar to Buerke et al which demonstrated IGF-I attenuation 
capacity of myocardial injury after ischemia as well as Johnsen et al which identified low IGF-I 
levels indicative of increased ischemic stroke risk. Along with these protective aspects, IGF-I has 
been shown to be of potential use in the treatment of various neurodegenerative diseases by its 
ability to shield/affect the survival of neurons and glial cells within the CNS and parasympathetic 
nervous system (PNS) (Doré et al. 1997). Correspondingly, IGF-I protected against amyloid-β 
toxicity, potentially acting as a therapeutic in Alzheimer’s disease (Wei et al. 2002) and restored 
function in a model of Parkinson’s disease by protecting dopaminergic neurons (Ebert et al. 
2008). As these studies show, IGF-I has the potential to protect cells from situational injury 
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resulting in improved conditions of a number of diseases, unfortunately this is not always the 
case as examined in the next section. 
 In some injuries or diseases, increased IGF-I can actually be a detriment and in some 
cases increase the damage, susceptibility or progression of the disease. Thus, displaying a dual 
role in the body’s immune response. Some conditions with increased IGF-I expression increasing 
risk is in Crohn’s disease (CD) (Pucilowska et al. 2000), cancer/tumor progression (Shevah and 
Laron 2007), lifespan (Barbieri et al. 2003), and hypoxia/ischemia (Endres et al. 2007). In CD, 
IGF-I is increased in mesenchymal cells resulting in increased fibroblast and fibrosis which 
underlies the cause of the disease (Pucilowska et al. 2000). Interestingly, IGF-I deficiency 
showed a significant link to reducing risk of cancer and therefore has a role in the development 
of cancer (Shevah and Laron 2007). Similarly, hypoxic targets, such as HIF-1α, and increased 
IGF-I signaling are important for tumor progression by activating VEGF and increasing overall 
angiogenesis (Carroll and Ashcroft 2006). Also, recent studies have shown an increased role of 
IGF-I in impacting longevity and lifespan. In these studies, it was shown that mutations within 
IGF-I causing reductions in free serum/plasma levels of the growth hormone are apparent in 
long-lived individuals displaying a negative correlation with longevity (Barbieri et al. 2003). 
Contrarily to previous studies, IGF-I activity has also been shown to be damaging during and 
after hypoxia/ischemia insult. Chronic delivery of IGF-I systemically has been shown to increase 
brain lesion size following artery occlusion (Endres et al. 2007) and knocking out the important 
receptor mediating IGF-I activity results in protection against oxidant-induced lung injury 
(Ahamed et al. 2005). Taken together, these results reveal both a protective and harmful role for 
IGF-I depending on the situation and further investigation of this vital growth hormone is 
necessary in order to develop more effective treatments and therapies. 
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Conclusion 
In review, hypoxia is an effective immunomodulator of cellular activity acting in both a 
protective and occasionally damaging role. Canonically, tissues that experience low levels of 
oxygen, typically following trauma or injury, signal for increased angiogenesis, VEGF and IGF 
expression, and additional factors which HIF genes mediate. However, even though these 
signaling pathways are necessary for proper recovery from hypoxic conditions and required to 
save tissues from necrosis, they are often accompanied by unintended consequences such as 
inflammation and neuronal modification/attack. Importantly, these apparent consequences have 
been shown to be critical in the initiation, promotion, and support of a variety of diseases 
including cancer, tumors, cardiovascular and Alzheimer’s disease. In addition, many 
comorbidities such as cognitive impairment and anxiety/depressive-like behaviors were shown to 
be mediated through underlying hypoxic pathogenesis. Many of these pathways include the 
generation of classical inflammatory markers through mitochondrial dysfunction (e.g. oxidative 
stress) and metabolic/endoplasmic reticulum stress. But more recently, important findings have 
identified the role adenosine and IGF-I play in hypoxia-induced brain injury/insult as possible 
therapeutic targets for combating these central illnesses. Especially considering the ability of 
adenosine to promote inflammasome activity by increasing both caspase-1 and IL-1β makes 
understanding its full mechanism following hypoxia essential. Therefore, further investigation is 
needed to understand hypoxia-induced comorbidities in order to determine more successful and 
personalized treatments.  
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CHAPTER 2: HYPOXIA/REOXYGENATION ACTIVATION OF ADENOSINE-
DEPENDENT CASPASE-1 MEDIATED THROUGH NEURONAL INSULIN-LIKE 
GROWTH FACTOR-1 (IGF-I) CONTRIBUTES TO MEMORY RECALL 
IMPAIRMENT 
 
Abstract 
Hypoxia/reoxygenation is a critical event in the development of multiple adverse 
psychological outcomes, including anxiety-like behaviors and cognitive impairment. The role 
linking brain-based IL-1 to these various impairments, especially memory formation and recall, 
has been the focus of many studies yet the exact mechanism is undefined. More specifically, 
adenosine-dependent activation of caspase-1 has been shown to be a crucial mediator of 
hypoxia-induced brain-based cognitive impairment. In this study, we examined the mechanism 
underlying memory recall after an acute hypoxic incident. Following reoxygenation, 
confirmation of increased caspase-1 activity in the amygdala by 65% was determined using a 
novel ICV-IHC approach but no change was observed in the hippocampus. Mice were then 
injected with glyburide and DMPX to understand the involvement of K+ efflux/A2A AR. Both 
glyburide and DMPX significantly reduced the level of caspase-1 activation in the amygdala 
after hypoxia/reoxygenation. In correlation with the reduction in caspase-1 activation, both drugs 
restored novel object recognition memory and therefore memory recall. Caspase-1 activation was 
neuron-induced with greater co-localization of neurons and caspase-1 in the amygdala of 
hypoxic animals when compared to controls. Similarly, neuron-specific knockout of IGF-I 
significantly reduced caspase-1 activation in the amygdala following hypoxia/reoxygenation 
corresponding with correction of novel object recognition. Hypoxia/reoxygenation induced a 
significant increase in the phosphorylation of IRS-1 and p70SK but no change in IGF-I, PKA, or 
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cAMP. Therefore, these results show hypoxia-induced caspase-1 activation acts through A2A 
AR/K+ efflux agonism to promote neuronal IGF-I resulting in memory recall impairment. 
 
Introduction 
Acute hypoxia is known to be a contributing factor to an abundance of underlying 
psychological sequela (Caris et al. 2017) such as memory loss (Wu et al. 2013), anxiety 
(Nadlewska et al. 2002), and insomnia (Johansson et al. 2014). An acute hypoxic experience is 
the consequence of loss of oxygen resulting often in brain-based injury (Howard et al. 2011). 
The associated level of injury is typically correlated with the exposure time and magnitude of the 
loss of oxygen (Caris et al. 2017) and the necessary but equally damaging reoxygenation period 
following hypoxia which can result in multiple negative consequences such as increased cell 
death (Saikumar et al. 1998), inflammation (Johnson et al. 2007) and other associated damage 
(González-Correa et al. 2007). Typically, reoxygenation is associated with the return of oxygen 
in ischemic injuries, but reoxygenation has serious impacts without ischemia including the 
cognitive dysfunction associated with sleep apnea (Gozal et al. 2001; Nair et al. 2011) and other 
respiratory tract disorders such as chronic obstructive pulmonary disorder (COPD) (Stuss et al. 
1997), asthma (Waddell et al. 1967) and cystic fibrosis (Vichinsky et al. 1984).  
 
The resulting loss of oxygen following acute hypoxia has been shown to activate the 
interleukin (IL)-1 arm of the neuroimmune system (Johnson et al. 2007). Excessive brain-based 
IL-1 impacts multiple psychological processes including memory loss (Pugh et al. 2001) and 
depression (Rybnikova et al. 2007). A key component of these negative consequences is IL-1β 
(Johnson et al. 2007) and these adverse effects have been mitigated by the inhibition of the 
17 
 
significant IL-1β cleavage enzyme, caspase-1. Caspase-1 exists as an inflammatory caspase 
(Miao et al. 2011) and member of the cysteine-aspartic acid protease family as an intracellularly 
inactive proenzyme (Damiano et al. 2004). Caspase-1 is then activated after processing by Nod-
like receptor (NLR)-containing multi-protein inflammasomes (Miao et al. 2011). Once activated, 
caspase-1 directly processes pro-IL-1β enzymatically to the secretable mature form of IL-1β 
(Bauernfeind et al. 2009). Inflammasome activation, in particular the NLRP3 inflammasome, can 
be activated in a myriad of ways including various microbe amongst other danger signals 
(Schroder et al. 2010) such as reactive oxygen species (ROS) (Tschopp et al. 2010), uric acid 
(Lamkanfi et al. 2007), and ATP (Di Virgilio 2007). Previously, our lab has shown that 
activation of adenosine receptors results in increased caspase-1 activity after 
hypoxia/reoxygenation (Chiu et al. 2012). However, the exact mechanism and cell type 
associated with this adenosine-dependent activation of caspase-1 has yet to be elucidated.  
 
Interestingly, membrane damage as a result of membrane destabilization and stress can 
result following hypoxia/reoxygenation injury and has been shown to increase extracellular 
concentrations of ATP, ADP and adenosine (Calabresi et al. 1995; Guinzberg et al. 2006). These 
increases in adenosine can be greater than 100x following a hypoxia/ischemic episode (Hagberg 
et al. 1987) where the neurotransmitter can be recognized by all classes of G protein-coupled 
adenosine receptors (ARs) including the A1 and A2A receptor (Fredholm et al. 2001). 
Specifically, the activation of the A1/A2A ARs have been shown by our group previously to be a 
critical danger signal for the stimulus of caspase-1 activity (Chiu et al. 2012; Chiu et al. 2014). 
Interestingly, adenosine receptors non-selective agonists have been shown to increase insulin 
growth factor-I (IGF-I) activity by as much as 11-fold (Grant et al. 1999) demonstrating the 
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capacity for these ubiquitous receptors to impact a key growth hormone. IGF-I is most notably a 
developmental hormone associated with the control of cell cycling and proliferation (Dupont and 
Holzenberger 2003), as well as energy metabolism and maintenance (Desbois-Mouthon et al. 
2006; Rowland et al. 2011) by acting through phosphatidylinositol-3-kinase (PI3K) and mitogen-
activated protein kinase (MAPK) molecular cascades (Russo et al. 2005). Often this important 
growth factor has been shown to be neuroprotective within the central nervous system (CNS) 
following acute brain injury, especially in some hypoxia-ischemia models (O’Donnell et al. 
2002; Liu et al. 2011; Guan et al. 2003). However, recent studies have posited that IGF-I 
signaling can actually promote injury through increased inflammation and oxidative damage 
when present in the CNS following an acute challenge (Endres et al. 2007; Yan et al. 2014; 
Ahamed et al. 2005; Cadoret et al. 2009). Of particular interest, locally blocking IGF-IR 
signaling in neurons of the forebrain protects animals from a hypoxia-ischemia insult (De 
Magalhaes Filho et al. 2016). The complete mechanism by which neuron-produced IGF-I confers 
protection or damage has yet to be fully understood. Therefore, this study was conducted to 
further elucidate the fundamental mechanism involving the induction of adenosine-dependent 
caspase-1 activation through neuronal IGF-I cells resulting in impairment of memory recall after 
acute hypoxia/reoxygenation. 
Methods 
Animals- The use of animals was in accordance with the Institutional Animal Care and 
Use Committee (IACUC) approved protocols at the University of Illinois. Adult C57BL/6J male 
mice (12-16 weeks old) were purchased from Jackson Laboratories (Bar Harbor, ME). Mice 
were group-housed (8 per cage), unless otherwise noted, in shoebox cages (length 29.9 cm; 
width 18.4 cm; height 12.5 cm) and allowed free access to food and water. Mice were allowed a 
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minimum of 24 hours to acclimate to cage environment. Housing temperature (72 °F) and 
humidity (45–55%) were controlled as was a 12/12 h reversed dark-light cycle (light = 1000-
2200 h). All behavioral and biochemical experiments were performed in the dark cycle and 
separate cohorts used to eliminate repeated measures as a factor. Total number of mice being 
used was 160. 
 
Hypoxia/Reoxygenation- As we have previously described (Sherry et al. 2009; Chiu et al. 
2012), mice were transferred from their home cages to a BioSperix ProOx/A-Chamber 
Biological Atmosphere System (Biospherix, Lacona NY) and subjected to either a 6% oxygen + 
94% nitrogen environment (hypoxia) or an atmospheric air environment (normoxia) for 2 h. 
After exposure mice were returned to their respective home cages for their respective 
reoxygenation allotted time. 
 
Injectables- Adenosine (Akorn, Lake Forest, IL) was administered IP at a dose of 2 
mg/kg/mouse 30 minutes prior to harvesting tissues. biotin-Ac-YVAD (AnaSpec, Fremont, CA) 
was administered ICV at a dose of 100 ng/µl/mouse 30 minutes post-hypoxia. Glyburide (Sigma-
Aldrich, St. Louis, MO) was administered IP, as described in Chiu et al. 2014, 30 minutes prior 
to hypoxia. 3,7-dimethyl-1-prop-2-ynyl-purine-2,6-dione (DMPX) (Sigma-Aldrich, St. Louis, 
MO) was administered IP at a dose of 5 mg/kg/mouse 30 minutes prior to hypoxia. 
 
Activated Caspase-1 Labeling- 30 minutes following hypoxia, mice were deeply 
anesthetized with ketamine/xylazine (80mg/kg/ 12mg/kg) then were injected with 100 ng of 
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biotin-YVAD-CMK ICV directly into the cerebrospinal fluid using a microinjection unit 
attached to a Kopf stereotaxic (Tujunga, California). 2 hours following biotin-YVAD-CMK 
injection mice were euthanized using CO2 and perfused with ice cold PBS followed by 4% 
paraformaldehyde. Brains were sectioned at 1.5 and 3.5 mm from the interaural coronally using a 
Mouse Brain Slicer (Zivic Insttruments, Pittsburgh, PA). Slices were fixed in 4% 
paraformaldehyde for 24 hours then paraffin embedded. 5μm slices from the two sections were 
blocked with hydrogen peroxide (Peroxidazed (PX968)) and labeled with SS HRP Label (4+ 
Strep HRP Label (HP604)), stained with liquid 3.3’-diaminobenzidine (DAB) chromogen (IP 
FLX DAB (IPK5010)), counterstained with hematoxylin (Cat Hematoxylin (CATHE)) and 
mounted and cover-slipped with the BioCare IntelliPATH. The entire slide was imaged at 40x 
with a NanoZoomer 2.0-HT (Hamamatsu, Bridgewater, NJ). Area of staining was measured 
using ImageJ (National Institute of Health). 
 
Dual-Stain Protocol- Similar to above, slices were fixed in 4% paraformaldehyde for 24 
hours then paraffin embedded. 5μm slices from the two sections were blocked with hydrogen 
peroxide (Peroxidazed (PX968)) and labeled with SS HRP Label (4+ Strep HRP Label 
(HP604)), stained with liquid 3.3’-diaminobenzidine (DAB) chromogen (IP FLX DAB 
(IPK5010)), washed, labeled with neuron specific enolase (Abcam NSE (ab53025)), labeled with 
rab-rod AP polymer (MACH 4 Universal AP Polymer Kit (RMR625)), stained with liquid Warp 
Red chromogen (IP Warp Red (IPK5024)), counterstained with hematoxylin (Cat Hematoxylin 
(CATHE)) and mounted and cover-slipped with the BioCare IntelliPATH. The entire slide was 
imaged at 40x with a NanoZoomer 2.0-HT (Hamamatsu, Bridgewater, NJ). Co-localization was 
determined based on the percentage of co-labeled NSE-caspase-1 labeled cells divided by total 
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number of caspase-1 labeled cells and analysis completed using ImageJ (National Institute of 
Health). 
 
Novel Object Recognition (NOR)- NOR testing was performed as described in York et al. 
2012 and Chiu et al. 2012. In brief, individually grouped mice were transferred to a shoebox-
style training arena (26 cm x 48 cm x 21 cm) containing two identical objects (LEGO toys in 
distinct configurations) on one side of the arena 1 hr prior to hypoxia. Mice were allowed to 
investigate the objects for 10 minutes as training. After training, mice were returned to their 
home cage prior to hypoxia. After hypoxia, subject mice were transferred 1 hr post-hypoxia to 
individual testing arenas, without food but with bedding present, where they were presented with 
one familiar object and one novel object in a spatial location comparable to training. Mouse 
exploration was video recorded for 5 min and evaluated by using EthoVision XT 7 video 
tracking software (Noldus Information Technology, Leesburg, VA). A discrimination index was 
used to determine cognition and calculated as the amount of time spent examining the novel 
object divided by the total time spent investigating both objects. 
 
IGF-I ELISA- 2 hrs post-hypoxia and 30 minutes post-adenosine injection, perfused 
amygdala and hippocampus brain sections were frozen in liquid nitrogen then freeze fractured in 
reaction buffer containing 50 mM CaCl, 10% glycerol, 1 mM DTT, 1 mM EDTA, 1 mM 
bestatin, 1 mM pepstatin, 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride and 50 
mM HEPES, pH 7.4 using the TissueLyser II. Lysates were clarified at 16,000 x g for 15 min at 
4º C and the supernatant protein concentrations determined using the DC Protein Assay. IGF-I 
concentrations were determined using the R & D Systems Mouse/Rat IGF-I Quantikine ELISA 
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Kit. In brief, samples were incubated with the kit-provided substrate coated plate for 2 hours and 
measured spectrophotometrically at 450 nm. Results are expressed as absolute values with units 
pg/ml per total sample protein. 
 
PKA Activity- Similar to previous Chiu et al. 2012, 2 hours post-hypoxia, perfused 
amygdala and hippocampus brain sections were frozen in liquid nitrogen then freeze fractured in 
reaction buffer containing 50 mM CaCl, 10% glycerol, 1 mM DTT, 1 mM EDTA, 1 mM 
bestatin, 1 mM pepstatin, 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride and 50 
mM HEPES, pH 7.4 using the TissueLyser II. Lysates were clarified and supernatant protein 
concentrations normalized to 1.8 mg/ml with reaction buffer, as above. PKA activity was 
determined using the Enzo Life Science PKA Kinase Activity Kit. In brief, samples were 
incubated with the kit-provided substrate coated plate for 90 min and phosphorylated 
tetramethylbenzidine measured spectrophotometrically at 450 nm. Results are expressed as 
relative change from control. 
 
cAMP Activity- 2-hours post hypoxia, perfused whole brains were frozen in liquid 
nitrogen then freeze fractured in reaction buffer containing 50 mM CaCl, 10% glycerol, 1 mM 
DTT, 1 mM EDTA, 1 mM bestatin, 1 mM pepstatin, 1 mM 4-(2-aminoethyl) benzenesulfonyl 
fluoride hydrochloride and 50 mM HEPES, pH 7.4 using the TissueLyser II. Lysates were 
clarified and supernatant protein concentrations normalized to 1.5 mg/ml with reaction buffer, as 
above. cAMP concentration was determined using the Abcam cAMP Direct Immunoassay Kit 
(Cambridge, United Kingdom). In brief, samples were incubated with HRP conjugate and read 
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for HRP activity using a spectrophotometer at 450 nm. Results are expressed as relative change 
compared to controls. 
 
Phosphoprotein Bioplex Assay- Similar to methods we have previously described (Sherry 
et al. 2007; Chiu et al. 2012), whole brains were harvested 1 hr after hypoxia, frozen in liquid 
nitrogen then freeze fractured, in a homogenization buffer containing 50 mM NaCl, 10% 
glycerol, 1 mM DTT, 2 mM sodium orthovanadate, 250 nM okadaic acid, 1:200 Protease 
Inhibitor Cocktail III (Calbiochem, Darmstadt, Germany) and 50 mM HEPES, pH 7.4 using the 
TissueLyser II. Lysates were clarified at 16,000 x g for 15 min at 4º C and the supernatant 
protein concentrations determined using the DC Protein Assay. p-IR-beta, p-IRS-1, p-AKT, p-
ERK1/2, p-MAPK, p-NFkB, and p-70SK were measured in 50 µL of lysate using a Bio-Plex 
phosphoprotein assay (Bio-Rad, Hercules, CA) and Luminex 100 System (Luminex, Austin, TX) 
following the instructions of the manufacturer. Results are expressed as pg/ml per unit total 
protein.  
 
Cre-Lox Mice- Animals used for the cre-lox behavioral testing and caspase-1 analysis 
were IGF-I flox/flox mice targeting exon 4 by flanking with loxP sites and backcrossed for 10 
generations in order to place them on C57BL/6J background. These mice were then bred with N-
CreE+/- mice (B6; 129S6-Tg(Camk2a-cre/ERT2)1Aibs/J, Jackson Laboratory, Bar Harbor, 
Maine) which are N3 on a C57BL/6J genetic background and possess cre-recombinase under the 
control of the mouse Camk2a promoter. N-CreE+/- animals were bred with IGF-I flox/flox and 
genotyped in successive generations until homozygous N-CreE-IGF-I flox/flox were developed. 
The homozygous animals were bred and their respective offspring used in the study. NCreE+/+ 
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mice used as controls. Both controls and knockout mice were administered Tamoxifen (500 
mg/kg, Envigo, Somerset, NJ) in diet fed ad libitum for 5 days to promote excision of targeted 
gene. Mice were then transferred back to standard chow for a minimum 7 days prior to testing.  
 
Statistics- Analysis was conducted using Sigma Plot 11.2 (Systat Software, Chicago, IL). 
To test for statistical differences, one-way and two-way analysis of variance (ANOVA) tests 
were used as indicated. Mann-Whitney Rank Sum Test used when variance testing failed. 
Tukey’s test was used for post-hoc pair-wise multiple comparison procedures. Results shown as 
means ± SEM. Statistical significance was determined as p < 0.05. 
Results 
Hypoxia/reoxygenation results in dramatic increase in caspase-1 activity in the amygdala 
without impacting hippocampal levels. Since hypoxia/reoxygenation is capable of producing 
inflammation (Eltzschig and Carmeliet 2011) and more specifically caspase-1 activity in the 
brain (Chiu et al. 2012). We evaluated the localized activation of caspase-1 activity in the 
amygdala and hippocampus via a novel ICV-IHC method. Two and a half hours of 
reoxygenation following hypoxic insult resulted in increased active caspase-1 in the amygdala 
but not the hippocampus as evidenced by Fig. 2.1A representative slides. Fig. 2.1B shows an 
89.7% increase in active caspase-1 in the area stained following hypoxia in the amygdala when 
compared to normoxic controls (Mann-Whitney Rank Sum Test- (Norm vs Hyp)- U = 24.0; P = 
0.006). No difference in the hippocampus in caspase-1 activity was observed between hypoxic 
and normoxic mice. 
 
25 
 
Potassium efflux and A2A adenosine receptor selective antagonists reduce 
hypoxia/reoxygenation-induced caspase-1 activity in the amygdala as well as restoration of 
memory recall. Potassium efflux (Gurcel et al. 2006) and adenosine receptors (Chiu et al. 2012) 
are crucial to caspase-1 activation. Therefore, antagonists targeting both potassium efflux and the 
A2A AR were used and caspase-1 activity evaluated within the amygdala and hippocampus. Fig. 
2.2A shows a 90% reduction in hypoxia-induced caspase-1 activation in the amygdala after 
glyburide administration (two-way ANOVA: Treatment (Norm vs Hyp)- P = 0.011; Drug (Sal vs 
Gly)- P = 0.066; Hypoxic (Sal vs Gly)- P = 0.019; Saline (Norm vs Hyp)- P = 0.003). Glyburide 
administration did not impact caspase-1 activity in the hippocampus following 
hypoxia/reoxgyenation, Fig. 2.2B. Representative slide images from the amygdala and 
hippocampus of hypoxic mice with either saline (Sal) or glyburide (Gly) injection stained for 
active caspase-1 are shown in Fig. 2.2C&D. Fig. 2E shows a 187% reduction in hypoxia-induced 
caspase-1 activation in the amygdala after 3,7-dimethyl-1-prop-2-ynyl-purine-2,6-dione (DMPX) 
administration (two-way ANOVA: Treatment (Norm vs Hyp)- P = 0.002; Drug (Sal vs DMPX)- 
P < 0.001; Hypoxic (Sal vs DMPX)- P < 0.001; Saline (Norm vs Hyp)- P < 0.001). DMPX 
administration did not impact caspase-1 activity in the hippocampus following 
hypoxia/reoxgyenation, Fig. 2.2F. Representative slide images from the amygdala and 
hippocampus of hypoxic mice with either Sal or DMPX injection stained for active caspase-1 are 
shown in Fig. 2.2G&H.  
 
Normoxic and hypoxic mice were examined after administration of either glyburide or 
DMPX using a novel object recognition (NOR) task for memory recall (Fig. 2.3A&B). The NOR 
task is an efficient and objective determination of hippocampal-independent memory (McGaugh 
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2004; Wan et al. 1999; Brown and Aggleton 2001). Following glyburide administration, 
hypoxic-mice showed recovered performance and improved memory recall in the NOR task 
compared to hypoxic-saline controls (two-way ANOVA: Treatment- (Norm vs Hyp)- P = 0.802; 
Drug- (Sal vs Gly)- P = 0.050; Hypoxic- (Sal vs Gly)- P = 0.002; Saline- (Norm vs Hyp)- P = 
0.024; Fig. 2.3A). Similarly, administration of DMPX alleviated hypoxia-induced memory 
impairment by restoring novel object preference performance in treated mice when compared to 
saline controls via discrimination index (two-way ANOVA: Treatment- (Norm vs Hyp)- P = 
0.016; Drug- (Sal vs DMPX)- P = 0.006; Hypoxic- (Sal vs DMPX)- P < 0.001; Saline- (Norm vs 
Hyp)- P < 0.001; Fig. 2.3B). 
 
Hypoxia/reoxgyenation induction of caspase-1 activity contributed significantly by 
neuronal activity in the amygdala. Determination of the major contributing cell capable of 
producing caspase-1 activation following hypoxia/reoxygenation is necessary for complete 
elucidation of the respective mechanism. Therefore, in Fig. 2.4 mice that were exposed to 
hypoxia for 2 hrs and allowed to reoxygenate for another 2 hrs were stained for both Biotin-
YVAD-CMK (Caspase-1 inhibitor) and neuron specific enolase (NSE) via immunohistochemical 
methods, as described previously. Hypoxic mice showed a significantly increased percent of 
NSE-caspase-1 labeled cells/total caspase-1 labeled cells when compared to normoxic mice 
(one-way ANOVA: Norm vs Hyp- P = 0.014; Fig. 2.4A). Analysis show neurons provide a 
majority of caspase-1 activity by a measure of 67.5%. Representative slide images from the 
amygdala of normoxic and hypoxic mice stained for active caspase-1 and NSE are shown in Fig. 
2.4B&C. 
 
27 
 
Conditional cre-lox mice with deletion of IGF-I in neurons show reduced caspase-1 
activity in the amygdala and restored memory recall following a hypoxia/reoxygenation 
challenge. IGF-1 significantly contributes following hypoxic exposure (Joung et al. 2007) as 
well as memory (Trejo et al. 2008). Therefore, evaluation of caspase-1 activation and memory 
recall following 2 hours of hypoxia with localized IGF-I neuronal ablation was examined. Fig. 
2.5A illustrates the loss of IGF-I in neuronal cells of the amygdala reduces caspase-1 activation 
following hypoxia/reoxygenation compared to hypoxic controls and restores levels similar to 
normoxic mice (two-way ANOVA: Treatment- (Norm vs Hyp)- P = 0.045; Genotype- (NCRE vs 
IGF1)- P = 0.012; Hypoxic- (NCRE vs IGF1)- P < 0.001; NCRE- (Norm vs Hyp)- P = 0.002). 
There was no impact on hippocampal caspase-1 activation due to genotype following 
hypoxia/reogyenation exposure as shown in Fig. 2.5B. Representative slide images from the 
amygdala and hippocampus of hypoxic mice with either genotype NCRE or IGF1 stained for 
active caspase-1 are shown in Fig. 2.5C&D. 
 
To determine the role IGF-I reduction in neurons has on memory recall following 
hypoxia/reoxygenation, mice were tested for NOR task 1 hour after hypoxic exposure. Fig. 2.5E 
indicates that IGF-I neuronal knockout mice significantly enhances preference for the novel 
object when compared to NCRE controls following hypoxic exposure (one-way ANOVA: 
Hypoxic- (NCRE vs IGF1)- P = 0.025). No significant changes were observed between 
genotypes in normoxic treatment groups. 
 
Whole brain changes in phosphorylation of the IRS-1 and p70SK genes but no differences 
within either the hippocampus and amygdala of IGF-I, PKA, and cAMP activity. To further 
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elucidate the role of IGF-I in memory recall following hypoxia/reoxygenation, downstream 
products of IGF-I activation were examined via phosphoprotein analysis. Fig. 2.6A shows a 
174% and 123% increase in phosphorylated IRS-1 and p70SK in whole brains, respectively, 
following 1 hr of reoxygenation (one-way ANOVA: p-IRS-1- (Norm vs Hyp)- P = 0.029; p-
p70SK- (Norm vs Hyp)- P = 0.031). Fig. 2.6B&C demonstrates no change in absolute IGF-I 
induction following either hypoxia/reoxygenation or adenosine injection. No differences were 
observed in PKA activity (Fig. 2.6D) or cAMP (Fig. 2.6E) following hypoxia with 2 hours of 
reoxygenation. 
Conclusion 
Hypoxia presents itself in a variety of negative health aspects especially in psychosocial 
issues, such as depression as evidenced by an increase in suicide rates at higher altitudes (Young 
2013), and learning problems following acute hypoxic exposure (Wu et al. 2013; Chiu et al. 
2012; Berggren et al. 1987). These issues are typically unassociated with long-term hypoxia and 
occur largely with short-term loss of oxygen or exposure to high altitudes (Caris et al. 2017), 
additionally acute hypoxia can be apparent in other disease states such as obesity (Hosogai et al. 
2007). Considering that a sizeable portion of the population lives at an altitude capable of 
producing hypoxia-related maladies (Wu et al. 2013), such as Denver, and obesity is a leading 
epidemic amongst the public (Nestle and Jacobson 2000). It is important to determine the 
mechanism underlying these various abnormalities in order for efficient mediation techniques or 
treatments to be developed.  
 
Origination of these hypoxia-induced memory loss issues has long been studied (Sara and 
Lefevre 1972; Beatty et al. 1987), but typically these studies have explained the associated 
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memory loss with apoptosis and neuronal cell death (Maiti et al. 2008), as well as inflammation 
(Udayabanu et al. 2008; De Paula et al. 2009) which is typically associated with ischemia. 
However, we have previously shown our hypoxia/reoxygenation model of 6% oxygen exposure 
does not result in cell death and neuroinflammatory markers (Kyff et al. 1989; Johnson et al. 
2007), or gliosis (Chiu et al. 2012). Previously in Chiu et al. 2012, it was determined that brain-
based caspase-1 activity in the amygdala was responsible for hypoxia-induced anterograde 
amnesia. Therefore, this study was able to confirm the role brain-based caspase-1 induction has 
following hypoxia/reoxygenation using a novel investigative technique injecting Biotin-YVAD-
CMK, a caspase-1 inhibitor, intracerebrovascular (ICV) into the brain and analyzing via 
immunohistochemistry (IHC) methods. Similarly, a significant increase in caspase-1 activity 
following 2 hrs of reoxygenation after hypoxic exposure in the amygdala but no difference was 
observed in the hippocampus (Fig. 2.1B). These findings support the concept that caspase-1 and 
likely IL-1 production are critical in producing negative behavioral alterations. 
 
Another important finding is that hypoxia-induced retrograde amnesia, as evidenced by 
impairment in the NOR task, was corrected by administration of glyburide and DMPX prior to 
hypoxic exposure (Fig. 2.3A&B). This finding correlates with Fig. 2A&E showing the ability for 
both glyburide and DMPX to reduce caspase-1 levels in the amygdala. These results are not 
surprising as glyburide is a significant antagonist for potassium efflux (Billman et al. 1993), 
which recently has been shown to be a significant activator of the inflammasome (Gurcel et al. 
2006) and therefore downstream producer of caspase-1. This result suggests that potassium 
efflux is apparent during acute hypoxia and is capable of activating caspase-1 resulting in 
retrograde amnesia. Interestingly, we demonstrated the ability for glyburide to restore NOR 
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memory after a high-fat diet challenge (Gainey et al. 2016) by increasing GSH:GSSG to combat 
oxidative stress. Additionally, Chiu et al. 2012 suggests that adenosine receptors (AR) are 
responsible for hypoxia-induced memory loss, with the suggestion being A1 or A2A ARs being 
the critical mediators of caspase-1 activation. Thus, use of the particularly selective A2A AR 
antagonist (Seale et al. 1988), DMPX, in being able to reduce both caspase-1 and restoration of 
memory recall following hypoxia provides evidence that the A2A AR is a significant mediator 
for these associated behavioral comorbidities. Restoration of a hippocampal-independent 
memory task, such as NOR (Gainey et al. 2016; McGaugh 2004; Wan et al. 1999; Brown and 
Aggleton 2001), following hypoxia is not surprising as induction of caspase-1 is localized to the 
amygdala and not the hippocampus (Fig. 2.1B; Fig. 2.2A&E). These results are contrary to 
Udayabanu et al. 2008 in which retrograde amnesia was impacted amongst various hippocampal-
dependent tests but their model used significantly greater length and a higher oxygen level at 6 
hrs of 7% oxygen. Importantly, hypoxia results in increased amygdala caspase-1 via potassium 
efflux and A2A AR activation causing impaired memory recall. 
 
Remarkably, we determined that the cell type contributing overwhelmingly to the 
induction of caspase-1 activity in the amygdala following hypoxia/reoxygenation is neuronal 
cells (Fig. 2.4A). This observed co-localization and contribution of neuronal cells is not 
surprising however, as Chiu et al. 2012 showed absence of gliosis/astrocytosis and the ability for 
hypoxia to directly injure neurons as a primary target being already known (De Magalhaes Filho 
et al. 2015). In addition, neurons are crucial to the regulation of memory recall and damage to 
neuronal cells is typical of human amnesic subjects (Martin et al. 2005; Andrade et al. 2008). 
Therefore, we confirm the contribution of neurons in the process of retrograde amnesia wherein 
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neuronal cells influence adenosine-dependent activation of caspase-1 and likely subsequent IL-
1β production. However, these results do not preclude the involvement of additional immune 
cells such as endothelial or oligodendrocytes especially as these cells present with ubiquitous 
A2A AR representation (Mills et al. 2011; Melani et al. 2009).  
 
As previously discussed, adenosine agonism has the ability to up-regulate the critical 
growth hormone IGF-I (Grant et al. 1999), insulin-like growth factor-1, therefore it is necessary 
to investigate the role IGF-I has on caspase-1 activation and retrograde amnesia. Additionally, 
targeting neurons specifically is an important aspect of this study considering previous findings 
in Fig. 2.4A. Thus, we were able to create a mouse model that ablated IGF-I in neuronal cells 
and observed the reduction of caspase-1 activity in the amygdala following 
hypoxia/reoxygenation (Fig. 2.5A). The IGF-1 knockout mice recovered memory recall after 
hypoxia exposure in correlation with the reduced caspase-1 activity (Fig. 2.5E). Similarly, 
several studies have demonstrated the ability for IGF-I to contribute to oxidative damage 
(Holzenberger et al. 2003), a consequence of hypoxia (Chiu et al. 2012; Maiti et al. 2006), as 
well as a study by Guan et al. 1998 indicating the capacity for IGF-I to amplify IL-1β-induced 
nitric oxide and additional negative effects. Even though IGF-I provides significant 
neuroprotection (Azcoitia et al. 1999; Vincent et al. 2004), these results suggest that localized 
IGF-I activity in neuronal cells is capable of inducing caspase-1 activity following a hypoxic 
event that is critical to retrograde amnesia incidence. 
 
In addition to the ability of hypoxia to induce caspase-1 activation, it can significantly 
increase the serine phosphorylation of IRS-1 and p70SK (Fig. 2.6A). These serine 
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phosphorylated proteins are significant contributors to negative associations of signal 
transduction, such as that of insulin resistance, and have been shown to be induced following 
inflammatory challenge via phosphatidylinositol-3’-kinase pathway (Gual et al. 2004; Kanety et 
al. 1995). These proteins in addition have the aptitude to modify IGF-I activity (Myers et al. 
2011; Popowski et al. 2008) with our results showing hypoxia possibly modifying IGF-I via 
phosphorylated IRS-1 and p70SK. This result is even better strengthened in that central 
activation of IGF-I activity was not directly impacted by hypoxia or adenosine administration 
(Fig. 2.6B&C) and lack of PKA or cAMP increased activation by hypoxia (Fig. 2.6D&E). It 
appears based on the results that the activation of IGF-I in neuronal cells driving caspase-1 
activity is relatively localized and possibly a peripheral response. This is a likely mechanism as 
IGF-I activities act on target cells largely via liver-derived cells (Dupont and Holzenberger 2003) 
and can cross the blood-brain barrier (Nishijima et al. 2010) especially during brain injury where 
IGF-I is locally produced by neurons (Liu et al. 2011). 
 
In summary, hypoxia presents itself in various pathological states such as memory loss 
(Chiu et al. 2012; Udayabanu et al. 2008) and additional behavioral outcomes such as anxiety-
like behaviors (Nadlewska et al. 2002) when exposed to a hypoxemic condition for both the 
short- and long-term. Therefore, we investigated the mechanism underlying the adenosine-
dependent caspase-1 activation within the amygdala following hypoxia/reoxygenation resulting 
in impaired memory recall presented as retrograde amnesia. The data presented shows 
hypoxia/reoxygenation acts through potassium efflux and the A2A AR to promote localized 
neuronal IGF-I production within the amygdala which produces caspase-1, and likely subsequent 
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IL-1β, to promote retrograde amnesia. Consequently, we should target potassium efflux, A2A 
AR, and localized IGF-I in order to develop efficacious treatments for amnesiac patients.   
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 CHAPTER 3: SHORT-TERM HIGH-FAT DIET (HFD) INDUCED ANXIETY-
LIKE BEHAVIORS AND COGNITIVE IMPAIRMENT ARE IMPROVED WITH 
TREATMENT BY GLYBURIDE1 
Abstract 
Obesity-associated comorbidities such as cognitive impairment and anxiety are an 
increasing public health burden that has gained prevalence in children. To better understand the 
impact of childhood obesity on brain function, mice were fed a high-fat diet (HFD) from 
weaning for 1, 3 or 6 wks. When compared to low-fat diet (LFD)-fed mice (LFD-mice), HFD-
fed mice (HFD-mice) had impaired novel object recognition (NOR) after 1 wk. After 3 wks, 
HFD-mice had impaired NOR and object location recognition (OLR). Additionally, these mice 
displayed anxiety-like behavior by measure of both the open-field and elevated zero maze 
testing. At 6 wks, HFD-mice were comparable to LFD-mice in NOR, open-field and elevated 
zero maze performance but remained impaired during OLR testing. Glyburide, a second 
generation sulfonylurea for the treatment of type 2 diabetes, was chosen as a countermeasure 
based on previous data showing its potential as an anxiolytic. Interestingly, a single dose of 
glyburide corrected deficiencies in NOR and mitigated anxiety-like behaviors in mice fed HFD-
diet for 3-wks. Taken together these results indicate that a HFD negatively impacts a subset of 
hippocampal-independent behaviors relatively rapidly, but that such behaviors normalize with 
age. In contrast, impairment of hippocampal-sensitive memory takes longer to develop but 
persists. Since single-dose glyburide restores brain function in 3-wk-old HFD-mice, drugs that 
1This chapter appeared in its entirety in the Frontiers of Behavioral Neuroscience and is 
referred to later in the dissertation as “Gainey et al. 2016”. Gainey SJ, Kwakwa KA, Bray JK, 
Pillote MM, Tir VL, Towers AE, Freund GG. (2016) Short-term high-fat diet (HFD) induced 
anxiety-like behaviors and cognitive impairment are improved with treatment by glyburide. 
Frontiers in Beh. Neurosci. 10: 156 
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block ATP-sensitive K+ (KATP) channels may be of clinical relevance in the treatment of obesity-
associated childhood cognitive and psychopathologies. 
Introduction 
With over 1 billion overweight and obese individuals afflicted, world-wide overnutrition 
is a significant threat to human health (Kelly et al. 2008). Obesity is associated with increased 
susceptibility to various comorbidities like depression (Leckie and Withers 1967; Luppino et al. 
2010), type 2 diabetes (Wannamethee and Shaper 1999), cardiovascular disease (Wannamethee 
et al. 1998), and cancer (Vainio and Bianchini 2002). One of the root causes of obesity is 
attributed to ingestion of dietary fat (Lissner and Heitmann 1995) which parallels the global 
permeation of a “western diet” (Cordain et al. 2005), where nearly 33% of total energy derives 
from fat. Predictably, extension of the obese phenotype into childhood is associated with added 
risks including diminished cognition and executive function (Liang et al. 2014). Additionally, 
obese children are susceptible to certain psychological complications like attention deficit 
hyperactivity disorder (ADHD), impulsivity, inattention and anxiety (Kalarchian and Marcus 
2012; Daniels et al. 2005). Current work demonstrates that childhood and adolescent obesity is 
especially disadvantageous as psychological illness and/or cognitive impairment later in life is 
the outcome even when consumption of a HFD is well in the past (Wang et al. 2015). Given the 
projected prevalence of childhood obesity in the next 30 years (Ogden et al. 2014) and the 
magnitude of associated co-morbidities, identifying therapeutics to address this accelerating 
health concern is crucial. 
 
Cognitive impairment and psychological abnormalities described in mouse models of 
diet-induced obesity (DIO) (Buettner et al. 2012) are often connected to a reduction in molecules 
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associated with neurogenesis and/or learning/memory such as BDNF (Molteni et al. 2002), 
dopamine (Kaczmarczyk et al. 2013) and inflammatory bioactives (Pistell et al. 2010). Recent 
studies demonstrate that DIO-associated brain dysfunction is not solely attributable to these 
mechanisms because hippocampal-based memory impaired by dietary fat occurs without 
significant change in BDNF (Heyward et al. 2013). Along similar lines, prolonged HFD-feeding 
does not upregulate brain-based IL-1β, TNF-α or IL-6 mRNA, even though sickness-like 
behaviors suggestive of brain inflammation are observed (Lavin et al. 2011). In juvenile animals, 
however, a HFD can impact working through pathways tied to glucocorticoids, neurogenesis and 
leptin (Boitard et al. 2012; Boitard et al. 2014; Boitard et al. 2015; Valladolid-Acebes et al. 
2013), and that this exposure impacted cognition in adulthood (Boitard et al. 2012). Although the 
brain-based complications of obesity are phenotypically well-described in animals, 
pharmacologic interventions that overcome such morbidities and are easily translated into 
humans are lacking. 
 
The second-generation sulfonylurea, glyburide, has long been used in the treatment of 
type 2 diabetes (Groop 1992; Kolterman et al. 1984). Glyburide inhibits sulfonylurea receptor 1 
(Sur1) preventing KATP channel function (Ashcroft 2005). It is this action on pancreatic β-cells 
that results in insulin release and improved blood glucose homeostasis (Niki et al. 1989; Zini et 
al. 1991). In turn, glyburide shows promise as a brain therapeutic due to its ability to cross the 
blood-brain barrier (Simard et al. 2012). Since it has been explored as countermeasure for 
traumatic brain injury (TBI), stroke, and spinal cord injury, it may be a suitable agent for other 
injuries and diseases (Simard et al. 2009; Simard et al. 2009; Patel et al. 2010; Kunte et al. 2007). 
While glyburide has been explored as a mitigating agent in Alzheimer’s disease (Lavretsky and 
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Jarvik 1992), neuroinflammation (Koh et al. 2011; Lamkanfi et al. 2009) and oxidative stress-
associated brain injury (Nazaroglu et al. 2009), little is known about the impact of sulfonylureas 
on mental function in the disease it was originally designed to treat. To determine whether the 
sulfonylurea, glyburide, positively impacts HFD-induced cognitive impairment and anxiety-like 
behaviors in young mice, such behaviors were examined in animals 1, 3, and 6 wks post-weaning 
fed a low-fat or high-fat diet. Thus, this pre-clinical study examines the role of glyburide as a 
deployable countermeasure to combat brain dysfunction associated with the early-life ingestion 
of a HFD. 
 
Methods 
Animals- The use of animals was in accordance with the Institutional Animal Care and 
Use Committee (IACUC) approved protocols at the University of Illinois. C57BL/6J male mice 
(3-4 wks old) were purchased from Jackson Laboratories (Bar Harbor, ME). Mice were placed 
on experimental diet 1 wk after (between 4-5 wks of age prior to puberty) arrival to allow for 
acclimation. Mice were group-housed (8 per cage), unless otherwise noted, in shoebox cages 
(length 46.9 cm; width 25.4 cm; height 12.5 cm) and allowed free access to food and water. 
Housing temperature (72 °F) and humidity (45–55%) were controlled as was a 12/12 h reversed 
dark-light cycle (light = 1000-2200 h). All behavioral and biochemical experiments were 
performed in the dark cycle and separate cohorts to eliminate repeated measures as a factor. 
Individual mice were used in a single behavioral test. Total number of mice being used was 396. 
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Diets, Weights, Blood Glucose- Mice were initially fed a standard chow of NIH-31 
modified open formula (Teklad 7013, Madison, WI) containing 18 % calories from protein, 6.2% 
from fat and 45% from carbohydrates. Mice were then transferred to fed open source uniform-
base diets, for respective studies, containing either 10% calories from fat (LFD) (D12450B, 
Research Diets, New Brunswick, NJ) or 60% calories from fat (HFD) (D12492, Research Diets, 
New Brunswick, NJ). Both diets provided 20% calories from protein. Mouse weight was 
recorded for the respective wks using an Adventurer Pro digital scale (Ohaus, Parsippany, NJ). 
Blood glucose testing was recorded for the respective wks by fasting mice for 12 hours during 
their light cycle and sampling tail blood.  For glyburide studies, blood glucose testing was 
conducted immediately post-behavior testing with ad libitum access to food.  Glucose was 
quantified by using an AlphaTRAK blood glucose monitoring system (Abbott Laboratories, 
North Chicago, IL). 
 
Food Intake- As previously described (York et al. 2012), mouse cohorts used to 
determine food intake were individually housed for up to 6 wks. Food intake was calculated 
daily as the difference in weight of food in the feed bowl before and after removal from the food 
intake arena. 
 
Plasma NEFAs- As described previously (Moon et al. 2014), mice were euthanized and 
blood collected via cardiac puncture using BD Microtainer Tubes with Lithium Heparin (BD 
Diagnostics, Franklin Lakes, NJ). Blood was centrifuged at 8,000 x g for 10 min at 4ºC. 
Supernatant was collected and analyzed. The resultant plasma non-esterified fatty acids (NEFA) 
were measured on an AU 680 Chemistry System (Beckman Coulter, Brea, CA) using an 
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enzymatic colorimetric NEFA test kit (Wako, Richmond, VA). This kit is designed to measure 
total NEFA levels excluding short-chain fatty acids. 
 
Injectables- Glyburide (6.6 mg/kg/mouse) (Sigma-Aldrich, St. Louis, MO) was 
administered IP as described (Chiu et al. 2014) immediately prior to novel object training for 
mice at 1, 3, and 6 wks on diet.  Mice were injected four hours prior to elevated zero maze 
measured in mice on diet for 3 wks only.   
 
NOR- Testing was performed as described in York et al. 2012 and Chiu et al. 2012. In 
brief, group housed mice were transferred to a shoebox-style training arena (26 cm x 48 cm x 21 
cm) containing two identical objects (LEGO toys in distinct configurations) on one side of the 
arena. Mice were allowed to investigate the objects for 24 hrs with food provided ad libitum. 
After training, mice were returned to their home cage for 1 hr. After the 1 hr refractory period, 
subject mice were transferred to individual testing arenas, without food but with bedding present, 
where they were presented with one familiar object and one novel object in a spatial location 
comparable to training. Mouse exploration was video recorded for 5 min and evaluated by using 
EthoVision XT 7 video tracking software (Noldus Information Technology, Leesburg, VA). A 
discrimination index was used to determine cognition and calculated as the amount of time spent 
examining the novel object divided by the total time spent investigating both objects. 
 
OLR-  Testing was performed as described (York et al. 2012) and was similar to NOR 
except that upon testing the subject mouse was re-exposed to two familiar objects (LEGO toys) 
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where one was placed at the opposite end from training. Spatial clues were placed on the outside 
of the cage to assist spatial determination. As above, mouse exploration was video recorded for 5 
min and evaluated by using EthoVision XT 7 video tracking software. A discrimination index 
was used to determine cognition and calculated as the amount of time spent examining the object 
in a novel location divided by the total time spent investigating both objects. 
   
Elevated zero-maze- Testing was performed as described in York et al. 2012. In brief, 
group-housed mice were individually housed for 24 hours. For testing, subject mice were 
individually placed within the high walls of an elevated zero-maze (57.15 cm outer diameter, 6 
cm track, 72 cm from the floor). The maze was composed of four quadrants with two areas 
having high walls (14 cm tall) and two areas without walls. Mouse exploration was video 
recorded for 5 min and evaluated by using EthoVision XT 7 video tracking software. Time spent 
in the open quadrants was defined as at least 50% of the body being outside of the high-walled 
areas. 
 
Open field test- As above, group-housed mice were individual housed for 24 hours. Mice 
were individually tested by placing subject mice in a lit novel open field arena (66 cm x 45.7 cm 
x 22.9cm) generating a 9 cm shadow from respective side walls (York et al. 2012). Mouse 
exploration was video recorded for 5 min and evaluated by using EthoVision XT 7 video 
tracking software. Time spent in the open area was equated to time spent in the non-shadowed 
areas. 
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Glutathione Assay- As previously described, PBS perfused brain regions were frozen in 
liquid nitrogen then freeze fractured (Kaczmarczyk et al. 2013) in reaction buffer containing 50 
mM NaCl (Fisher Scientific, Fair Lawn, NJ), 1 mM EDTA, 50 mM HEPES, pH 7.0 (USB 
Corporation, Cleveland, OH) using the TissueLyser II (Qiagen, Valencia, CA) at a rotational 
frequency of 30 s-1 for 2 minutes. Lysates were centrifuged at 10,000 x g for 15 minutes at 4 ºC 
and the supernatant recovered. The supernatant was deproteinated with an equal volume of 
metaphosphoric acid (Sigma-Aldrich, St. Louis, MO) and vortexing. Samples were re-
centrifuged at 8,000 x g for 5 min. Supernatant and pellet were saved. Glutathione, both reduced 
and oxidized, was determined using the Glutathione Assay Kit (Cayman Chemical, Ann Arbor, 
Michigan) following the manufactures instructions.  Glutathione (GSH) and glutathione disulfide 
(GSSG) were quantified using an ELx800 Absorbance Microplate Reader (BioTek Instrument, 
Winooski, VT) at 405 nm in five minute intervals for 30 minutes. Protein precipitates were 
eluted with reaction buffer and quantified using the DC Protein Assay (Bio-Rad, Hercules, CA). 
 
Quantitative PCR (qPCR)- Brain regions were dissected from PBS perfused whole brains 
and RNA isolated (York et al. 2012). RNA was reverse transcribed using the High-Capacity 
cDNA Reverse Transcription Kit (PN 4368813) (Applied Biosystems). The TaqMan Gene 
Expression primers used were: IL1R2 (Mm00439622_m1), brain derived neurotrophic factor 
(BDNF) (MM01334042_m1), Arc (Mm01204954_g1), iNOS (Mm00440502_m1), eNOS 
(Mm00435217_m1), casp1 (Mm00438023_m1), TXNIP (Mm01265659_g1), and SOD1 
(Mm01344233_g1). qPCR was performed on a 7900 HT Fast Real-Time PCR System (Applied 
Biosystems) using TaqMan Universal PCR Master Mix (Applied Biosystems). To compare gene 
expression, a parallel amplification of endogenous RPS3 (Mm00656272_m1) was performed. 
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Reactions with no reverse transcription and no template were included as negative controls. 
Relative quantitative evaluation of target gene to RPS3 was performed by comparing ΔCts, 
where Ct is the threshold concentration. 
 
Statistical Analysis- Data analysis was conducted using Sigma Plot11.2 (Systat Software, 
Chicago, IL). Body weight, fasting blood glucose (FBG), plasma non-esterified fatty acids 
(NEFA), food intake, NOR and OLR total investigation, elevated zero maze performance, open 
field testing, and PCR analysis used 1-way analysis of variance (ANOVA) to define the main 
effects followed by Tukey adjustment. All experiments with NOR and OLR discrimination index 
analyzed using a one-sample t-test comparing novel object preference to chance level of 0.5. The 
Kruskal-Wallis One-Way ANOVA on Ranks was used for GSH-GSSG ratio for main effect of 
diet and treatment in glyburide experiment, due to variance within groups. Glyburide 
experiments for blood glucose analyzed by 2-way analysis of variance and time spent in open of 
EZM and closed arm entries analyzed by 1-way analysis of variance test to determine the main 
effects of diet and treatment followed by a Tukey adjustment. Statistical significance was 
assumed at p < 0.05 and all data are presented as means ± SEM. 
 
Results 
HFD feeding for 3 wks increases body weight and blood glucose without impacting 
plasma NEFA concentrations, food ingestion, and inflammatory gene expression. To delineate 
the physiologic impact of the diets administered, the aforementioned biometrics were examined 
after 1, 3, and 6 wks of feeding. When HFD-mice were compared to LFD-mice at 3 and 6 wks 
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post feeding, there was a 30% and 42% increase, respectively, in fasting blood glucose. These 
findings correlated with a 13.4% and 28.4% rise in body weight, respectively (see Table 3.1). 
Interestingly, food intake was comparable in HFD-mice and LFD-mice, but this resulted in a 
37%, 28%, and 14% increase in calories ingested in HFD-mice after 1, 3, and 6 wks of feeding, 
respectively (see Table 3.1). Since HFD-associated brain-based inflammation is implicated in 
cognitive impairment, biomarkers of pro-inflammation were examined (Table 3.2). Interestingly, 
only hippocampal iNOS gene transcripts in HFD-mice showed an upregulation (99% vs LFD-
mice).  
 
HFD-mice develop object memory impairment and transient anxiety-like behaviors. 
HFD-mice and LFD-mice were examined after 1, 3, and 6 wks of diet using a NOR task (Fig. 
3.1A). NOR is an effective measure of hippocampal-independent memory (McGaugh 2004; Wan 
et al. 1999; Brown and Aggleton 2001). At 1 and 3 wks of diet, HFD-mice showed no preference 
for a novel object while LFD-mice showed preference for novel object over that of the familiar 
(one-sample t-test: 1 wk diet (LFD)- P < 0.001, 3 wk diet (LFD)- P < 0.022; Fig. 3.1A). After 6 
wks of diet, however, HFD-mice developed novel object preference which was similar to LFD-
mice (one-sample t-test: 6 wk diet (LFD)- P < 0.001, 6 wk diet (HFD)- P = 0.005; Fig. 3.1A). As 
an additional control, LFD-mice and chow-fed mice were compared. After 1 wk of feeding, 
NOR performance in chow-fed and LFD-mice were comparable (one-sample t-test: SC- P = 
0.002, LFD- P = 0.001; Fig. 3.1B). HFD-mice and LFD-mice demonstrated similar total object 
exploration times (one-way ANOVA: 1 wk diet- F1,22 = 0.08; P = 0.785, 3 wk diet- F1,22 = 1.22; P 
=0.281, 6 wk diet- F1,22 = 0.317; P = 0.579; Fig. 3.1D).  
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When hippocampal-memory was examined using OLR (Broadbent et al. 2004; Kesner et 
al. 1992; Jablonski et al. 2013) a persistent memory impairment was identified in HFD-mice 
compared to LFD-mice (Fig. 3.1B). After 1 wk of diet OLR was not impacted in HFD-mice 
(one-sample t-test: 1 wk diet (LFD)- P < 0.001, 1 wk diet (HFD)- P = 0.018; Fig. 3.1C). 
However, after a period of 3 and 6 wks of diet, HFD-mice lacked preference for the novel object 
whereas LFD-mice were able to distinguish between novel and familiar in the OLR task (one-
sample t-test: 3 wk diet (LFD)- P = 0.048, 6 wk diet (LFD)- P < 0.001; Fig. 3.1C). As above, diet 
did not impact combined object exploration (one-way ANOVA: 1 wk diet- F1,12 = 1.870; P = 
0.197, 3 wk diet- F1,14 = 1.281; P =0.277, 6 wk diet- F1,22 = 0.565; P = 0.460; Fig. 3.1E).  
 
To explore the impact of a HFD on anxiety-like behavior mice were tested in an elevated 
zero maze. After 3 wks of diet, time spent in the center of the EZM was reduced in HFD-mice 
compared to LFD-mice (one-way ANOVA: F1,30 = 10.333; P = 0.003; Fig. 3.1F). After 1 or 6 
weeks of diet, no difference between LFD-mice and HFD-mice was observed. To further explore 
if a HFD engendered trait as opposed to state anxiety (Moon et al. 2015), the open field test was 
utilized (Prut and Belzung 2003). HFD-mice spent a decreased amount of time in the open area 
of the OFT after 3 wks of diet when compared to LFD-mice (one-way ANOVA: F1,23 = 4.446; P 
= 0.047; Fig. 3.1G) and a similar amount of time in open after 1 or 6 weeks of diet. 
 
The GSH:GSSG ratio in the amygdala and hippocampus is reduced by an HFD. Since 
antioxidant capacity can impact memory (Alzoubi et al. 2013; Xu et al. 2014) brain GSH and 
GSSG was examined. After 3 wks of diet, there was a 54% and 43% increase in the GSH:GSSG 
ratios in the amygdala and hippocampus, respectively, when LFD-mice were compared to HFD-
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mice (Kruskal-Wallis One-Way ANOVA: amygdala- Q = 2.935; P =0.038; Fig. 3.2A, 
hippocampus- Q = 2.449; P =0.014; Fig. 3.2B). GSH:GSSG ratios were not different in LFD-
mice and HFD-mice after 1 and 6 wks of diet. Glyburide, which is known to increase antioxidant 
capacity (Patel et al. 1987; Chugh et al. 2001), raised the GSH:GSSG ratio 32.3% in the 
amygdala, of HFD-mice after 3 wks of diet (Kruskal-Wallis One-Way ANOVA: Amygdala- Q = 
2.748; P = 0.050; Fig. 3.2C). 
 
Glyburide reduces anxiety-like behaviors associated with a HFD after 3 wks of diet. 
After glyburide treatment, HFD-mice and LFD-mice spent equivalent times exploring the open 
and closed arms of the EZM (one-way ANOVA: Gly- F1,35 = 0.277; P = 0.602; Fig. 3.3A; F1,35 = 
0.166; P = 0.686; Fig. 3.3B). Importantly, injection of saline did not prevent anxiety-like 
behaviors associated with a HFD (one-way ANOVA: Sal- F1,33 = 4.460; P = 0.043; Fig. 3.3A; F1, 
33 = 6.264; P = 0.018; Fig. 3.3B). HFD-mice and LFD-mice did not differ in distance moved in 
the EZM (see Fig. 3.3C). As expected, post-hoc analysis showed that glyburide resulted in a 
16.5% reduction in non-fasting blood glucose (two-way ANOVA: HFD (Sal vs Gly)- Q = 4.506; 
P = 0.003; Fig 3.3D) and was associated with an overall drug effect (two-way ANOVA: Sal vs 
Gly- F1,41- 9.418; P = 0.004; Fig. 3.3D). 
 
Memory is improved by glyburide in HFD-mice after 3 wks of diet. At 1, 3 and 6 wks of 
diet, HFD-mice were unable to discriminate novelty in the NOR and OLR tasks (one-sample t-
test: 1 wk NOR (LFD-Sal)- P = 0.013, 1 wk (HFD-sal)- P = 0.249; Fig. 3.4A; 3 wk NOR (LFD-
Sal)- P = 0.008, 3 wk (HFD-Sal)- P = 0.089; Fig. 3.4B; 3 wk OLR (LFD-Sal)- P < 0.001, 3 wk 
(HFD-Sal)- P = 0.145; Fig. 3.4C; 6 wk OLR (LFD-Sal)- P = 0.005, 6 wk (HFD-Sal)- P = 0.644; 
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Fig. 3.4D). Interestingly, glyburide restored novelty preference in HFD-mice in the NOR task 
after 3 wks of diet (one-sample t-test: 3 wk NOR (LFD-Gly)- P = 0.025, (HFD-Gly)- P < 0.001; 
Fig. 3.4B), but not at 1 or 6 wks of diet (one-sample t-test: 1 wk NOR (LFD-Gly)- P = 0.018, 1 
wk (HFD-Gly)- P = 0.165; Fig. 3.4A; 6 wk OLR (LFD-Gly)- P = 0.002, 6 wk (HFD-Gly)- P = 
0.915; Fig. 3.4D) and not for OLR (one-sample t-test: 3 wk OLR (LFD-Gly)- P 0.014, 3 wk 
(HFD-Gly)- P = 0.351; Fig. 3.4C). 
 
Discussion 
Overweight children are predisposed to social and emotional complications tied to 
overnutrition including depression, low self-esteem and learning problems (Daniels et al. 2005; 
Mellbin and Vuille 1989). Origination of these learning problems is associated with inferior 
social skills (Dietz 1998) and anxiety (Williams 2001). In addition, controversy exists as to 
whether the overweight/obese phenotype is a root cause of childhood social and emotional 
problems or a sequela of resultant bullying (Eisenerg et al. 2003). In juvenile mice, a short-term 
(1-wk) HFD feeding impairs behavior as we have previously shown (Kaczmarczyk et al. 2013) 
and show here (Fig. 3.1A). Consistently, impaired NOR appears associated with short-term 
overnutrition, as opposed to impaired OLR which takes longer to manifest (3 wks) (Fig. 3.1B). 
Interestingly, this early impairment in NOR is not associated with FBG or plasma NEFAs but 
does positively correlate with energy intake (Table 3.1). These findings support the contention 
that learning problems associated with overnutrition are not entirely linked to the 
overweight/obese body type and its negative perception by industrialized peoples (Murray et al. 
2009; Holloway et al. 2011).    
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Another important finding is that impairment of OLR is longer lasting than impairment of 
NOR (Fig. 3.1). The advantage of using NOR and OLR for memory testing is that they are easy 
to perform, involve a similar paradigm but test different types of memory. NOR is much more 
hippocampal-independent than OLR (McGaugh 2004; Wan et al. 1999; Brown and Aggleton 
2001). In contrast, OLR is more dependent on spatial memory and is, thus, more hippocampal-
sensitive (Moses et al. 2005). Our findings are supported by recent work which shows that 23 
wks of HFD feeding in mice impairs OLR but not NOR (Heyward et al. 2013). In addition, we 
previously found that NOR was intact in HFD-mice on diet for 10-12 wks (Lavin et al. 2011). 
Taken together, the clinical significance of these works is their relationship to dementia and type 
3 diabetes (T3D) (de la Monte and Wands 2008).  
 
In T3D, lack of brain-based insulin production or the presence of brain-based insulin 
resistance (Biessels et al. 1998; Lannert and Hoyer 1998; Kodl and Seaquist 2008) precipitates 
memory dysfunction with symptomatology that overlaps that of Alzheimer’s disease (Deng et al. 
2009; Gasparini et al. 2001; Steen et al. 2005). Insulin is required for new memory creation by 
facilitating synaptic plasticity (van der Heide et al. 2006) and HFD-induced insulin/IGF-1 
resistance (Spielman et al. 2014) which appears important to T3D (Watson and Craft 2004; 
Vardy et al. 2007), especially in the hippocampus (McNay et al. 2010; Grillo et al. 2015). Given 
that HFD-mice have an elevation in FBG (Table 3.1), it is not surprising that impairment in 
hippocampal-dependent memory would be coincident (Fig. 3.1). Furthermore, HFD-induced 
elevations in FBG are caused by insulin resistance (Hirosumi et al. 2002). What was not 
anticipated is the rapidity by which a HFD impairs hippocampal memory. Although Beilharz et 
al 2014 found a similar phenomenon in their study, they concluded dietary sugar was the critical 
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factor. Sugar availability (~6.7% sucrose) was low in the diets used here. Thus, the hippocampal 
memory impairment observed appears dependent on fat content not sugar content. 
 
Previous work by Andre et al 2014 showed cognitive impairment and anxiety-like 
behaviors in mice fed a HFD. In their study, the postulated mechanism was tied to pro-
inflammatory cytokines and indoleamine 2,3-dioxygenase (IDO) activity. In contrast, 
Kaczmarczyk et al 2013 demonstrated no brain-based pro-inflammation in HFD-exposed mice 
and that IDO knockout mice were as susceptible to HFD-induced memory impairment as 
controls. A key difference between the studies of Andre et al and Kaczmarczyk et al was length 
of diet which was marked shorter in the latter study. Finally, Del Rio et al 2016 fed juvenile mice 
a short-term HFD resulting in cognitive deficits and an anti-depressive phenotype. Anxiety-like 
behaviors were not observed but the diet Del Rio et al used contained 45% fat as opposed to the 
60% used in this study. 
 
Why a HFD impacts hippocampal-independent functions like NOR and anxiety-like 
behaviors (Fig. 3.1A, D, E) rapidly and transiently is not clear. Previous work shows that 
oxidative stress is deleterious to brain function (Shukitt-Hale 1999; Droge and Schipper 2007). 
Specifically, anxiety-like behaviors manifest in mice when the GSH:GSSG ratio is reduced and 
cytosolic reactive oxygen species are increased (Llorente-Folch et al. 2013). While Fig. 3.2 
shows a drop in the GSH:GSSG ratio in HFD-mice compared to LFD-mice, this result appears a 
consequence of a HFD-induced suppression of a rise in the GSH:GSSG ratio. Interestingly, 7 
wks marks the approximate sexual maturation of male C57BL/6J mice (range 6-8 wks) (Fox and 
Witham 1997). Thus, male sexual maturation appears to be accompanied by a spike in the brain 
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GSH:GSSG ratio (Fig. 3.2). Mechanistically, this observation may be tied to an increase in 
testosterone since brain GSH in mice (Atroshi et al. 1990) is augmented by its administration. 
Additionally, sexual maturation increases the brain-active antioxidant dehydroepiandrosterone 
(DHEA) (Hopper and Yen 1975; McIntosh and Berdanier 1991; Aly et al. 2011), and DHEA 
favorably impacts the hippocampus in neurodegenerative diseases (Charalampopoulos et al. 
2008). Glyburide, especially during uncontrolled diabetes, increased reduced glutathione (Chugh 
et al. 2001). Such findings lend credence to our results demonstrating that glyburide increased 
the GSH:GSSG ratio in the brain. Although this effect appears brain-region specific, when the 
amygdala and hippocampus are compared.    
 
As Fig. 3.3 and 3.4 illustrate, an acute single dose of glyburide prevents HFD-induced 
memory impairment and anxiety-like behaviors indicating a role for this sulfonylurea in 
overnutrition-associated brain dysfunction in juvenile mice. Previously, we demonstrated that 
glyburide can block the activation of brain caspase-1 triggered by adenosine (Chiu et al. 2014) 
which is a key biologic in hypoxia-induced anterograde amnesia (Chiu et al. 2012). Since 
overnutrition is associated with endoplasmic reticulum (ER) stress (Mollica et al. 2011), it is 
theorized that the overnutrition-associated oxidative stress causes dysregulated purine 
metabolism (Al-Rubaye and Morad 2013). Subsequent cellular release of ATP and its precursors 
rapidly increases the interstitial concentration of adenosine (Chiu and Freund 2014) which 
through the A2A adenosine receptor triggers neuronal hyperpolarization in a KATP channel 
dependent manner (Popoli et al. 2002). Hence the relevance of adenosine to neurodegeneration 
and sleep (Stone 2005; Portas et al. 1997) and the interest in caffeine and its derivatives as 
neuroprotectants and CNS stimulants (Schwarzschild et al. 2002; Quintana et al. 2007). 
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Interestingly, a recent study identified the P2X7 receptor as a potential link between anxiety in 
rats and a HFD (Dutheil et al. 2016). This study, however, demonstrated HFD-induced brain 
inflammation as the potential mechanism. As noted, brain-based inflammation was not observed 
here likely due to our use of a short-term HFD feeding. Dutheil et al fed rats an HFD for 16 wks. 
Thus, different pathways are likely at play during the early (3 wk) and late (12-16 wk) 
manifestations of anxiety associated with a HFD. 
 
Glyburide can also boost SOD and catalase activity (Nazaroglu et al. 2009) mitigating 
oxidative stress in a canonical fashion. However, due to its limited impact on blood glucose (Fig. 
3.3), this mechanism seems unlikely In HFD-mice fed fat for at least 6 wks, memory-impairment 
may be due to hyperglycemia and the role blood glucose has in elevating extracellular amyloid-β 
protein in the hippocampus (Macauley et al. 2015). 
 
In summary, short-term HFD-feeding induces both cognitive impairment and anxiety-like 
behaviors which parallels symptoms seen in childhood obesity. These results coincide with a 
reduction in antioxidant capacity as exhibited by a suppressed GSH:GSSG ratio. Importantly, we 
demonstrated that administration of glyburide ameliorated hippocampal-independent brain 
function in HFD-mice. Unfortunately glyburide did not influence the hippocampal-sensitive 
memory task tested. Concordantly, glyburide increased the GSH:GSSG ratio in the amygdala but 
not in the hippocampus. Therefore, glyburide appears to selectively increase antioxidant capacity 
in the brain resulting in mitigation of hippocampal-independent impairments linked to a short 
term exposure to a HFD. These results suggest a unique use for glyburide in the prevention of 
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anxiety and hippocampal-independent cognitive impairment. While the exact mechanism of 
action requires further study, antioxidant capacity appears an important glyburide target. 
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CHAPTER 4: RAPID-APPLICATION OF WATER DURING LIVE-FIRE SCENARIOS 
MITIGATES DISEASE RISK AND IMMUNE DYSREGULATION OF FIRST-
RESPONDERS DURING OVERHAUL PERIOD 
 
Abstract 
Carcinogen and asphyxiate exposure during firefighting activities has been shown to 
present both acute- and long-term risks of various disease and illnesses especially with regards to 
cancer. To better understand the impact of smoke inhalation on increasing disease risk and 
possible immune dysregulation during firefighting activities, mice were placed in overhaul 
following a live-fire scenario after an interior or transitional tactical choice for 15 minutes. Lung 
tissue was harvested 2 hours post-overhaul exposure and RNA-seq analysis completed. Tactical 
choice impacted the environment significantly with a 10.3% reduction in average temperature 
between interior and transitional technique. Tactical choice significantly impacted differentially 
expressed gene profiles with interior technique resulting in substantially greater number of genes 
compared to transitional. Interior technique resulted in up-regulation of carcinogenic proteins 
such as Capn11 and Rorc with the corresponding down-regulation of immunomodulators such as 
Nr1d1 and Tnfrsf13c. Over-representation of disease pathways such as rap1 signaling, natural 
killer cell mediated cytotoxicity, and asthma were associated with interior technique. These 
results demonstrate overhaul after interior attack to be immune suppressed while promoting 
cancer-associated genes with transitional technique mitigating many of the associated risks 
during overhaul. Therefore, firefighters should use techniques that rapidly apply water (e.g. 
transitional) to mitigate their risk of cancer and immune related diseases.   
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Introduction 
Cancer mortality and incidence has been increasing in firefighters for several decades, 
and currently rivals cardiovascular disease as the leading cause of death in nearly 1 million 
United States fire fighters (Daniels et al. 2013; NFPA 2013) who respond to roughly 500,000 
structural fires every year (Karter 2012). Fire fighters are exposed to a variety of carcinogens 
when completing both live-fire and training scenarios, including dangerous chemicals such as 
polycyclic aromatic hydrocarbons (PAHs), carbon monoxide, and benzene (Fent et al. 2014). 
Even with substantial improvements in personal protective equipment (PPE), especially with 
regard to self-contained breathing apparatuses (SCBAs) and turnout gear, fire fighters are still 
routinely exposed to toxic contaminants via SCBA leakage or various dermal absorption 
methods (Burgess and Crutchfield. 1995; Caux et al. 2002; Laitinen et al. 2010). Risk of disease 
through exposure is minimalized through proper PPE usage. However, recent studies have 
demonstrated that proper usage and training is less than sufficient, with levels of SCBA use 
totaling 6% of the time at all fires and only being used for half the time at structural fires (Austin 
et al. 2001; Forgue 1992). Previous studies have determined that firefighters are at greater risk of 
cancer when compared to the general population (LeMasters et al. 2006; Daniels et al. 2013), 
even identifying possible causes such as diesel exhaust fumes or building particle debris 
exposure. However, these studies do not examine the biological and essential mechanisms 
involved in firefighting risk, leaving out critical details for mitigating the occurrence of cancer 
induction and mortality amongst firefighters and first responders.  
 
Some of the highest levels of risk of exposure during firefighting activities is not during 
the initial fire suppression phase but instead during the overhaul period, the time spent 
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examining the area for unextinguished fire inside attics/ceilings/walls lasting up to 30 minutes, 
which has been heavily associated with improper or little use of respiratory protection (Bolstad-
Johnson et al. 2010; Burgess et al. 2001). Removal of personal protective equipment, such as 
respiratory protection, during this critical window of firefighting activity not only exposes 
individual’s to harmful contaminants as previously described, but introduces new airborne 
particulates such as asbestos or organic vapors via structural exploration (Bolstad-Johnson et al. 
2000). These airborne particulates can present as a vehicle into the lungs and pulmonary systems 
of working firefighters, ultimately resulting in a decrease in pulmonary function (Brandt-Rauf et 
al. 1989; Large et al. 1990) and increase in lung permeability (Burgess et al. 2001). These lung 
conditions during firefighting activities combined with increased smoke inhalation, especially 
that of hypoxic chemicals such as carbon monoxide (Satran et al. 2005) and hydrogen cyanide 
(Purser et al. 1984), leave firefighters susceptible to tissue hypoxia. The dangerous environment 
produced by tissue hypoxia is associated with multiple diseases states including cardiovascular, 
inflammatory, and cancer (Brandt-Rauf et al. 1989; DeNicola et al. 1981; Giatromanolaki et al. 
2001). These associated risks, both short and long term, during overhaul activities have 
previously been described to be detrimental to the health of firefighters but little information is 
available on the specific genes regulating these various disease states.   
 
Interestingly, even with the updates in PPE over the decades for various firefighting 
activities, there has been little change in the approach and tactics to fighting structural fires. 
Recently the focus has changed to evaluating the effectiveness of these various techniques. 
Specifically understanding and adapting tactically to structures with increasing threats such as 
lightweight construction and synthetic combustibles will be important in providing a safe 
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operating environment for first responders (Schwarz and Wheeler 2009). For roughly five 
decades, the firefighting tactics have been represented as a priority list starting with rescue, 
exposures, confinement, extinguishment, overhaul, ventilation, and salvage (Goodson and Sneed 
1998) or better known as RECEO-VS. It has recently been important to evaluate the industry 
standard for efficiency, especially with regard to the phases of exposure, confinement, and 
extinguishment. Few studies have looked at varying tactical plans addressing these phases but 
two tactics are of particular importance, a standard interior offensive attack or a transitional 
offensive attack. These two tactics differ in the transitional attack having a quick exterior 
deployment and water application to the fire followed by an offensive attack in a less dangerous 
environment for the responders. However, the tactic does have limitations, especially if there is a 
need for rescue of individuals (Schwarz and Wheeler 2009; Baker 2014). There has been little 
understanding or experimentation detailing how change in tactical choice, such as interior versus 
transitional, results in physiological changes which may be important to reducing exposure to 
harmful contaminants responsible for disease risks. 
 
Therefore, the purpose of this study is to determine the overall effect of exposure during 
overhaul period of a modern live-fire environment on lung cancer and disease risk. More 
specifically, there is a need to determine gene transcripts and overexpressed genes in lung tissues 
that explain the high risks of cancer in the phase of post-fire extinguishment. The molecular 
understanding of lung injury during overhaul period of fire-fighting activities is important to 
determining efficacious treatments or appropriate protective equipment/training to mitigate risk. 
In addition to understanding the underlying biology, this study also tested different fire-fighting 
tactical choices, specifically interior versus a transitional attack, and how tactics impact the level 
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of toxic exposure seen in lung tissues. Based on the results of this study, there should be 
sufficient evidence to address current policies and techniques to reduce the increased levels of 
cancer incidence amongst fire-fighters and first responders. 
Methods 
Animals- The use of animals was in accordance with the Institutional Animal Care and 
Use Committee (IACUC) approved protocols at the University of Illinois. C57BL/6J male mice 
(10 weeks old) were purchased from Jackson Laboratories (Bar Harbor, ME). Mice were group-
housed (4 per cage), unless otherwise noted, in shoebox cages (length 29.9 cm; width 18.4 cm; 
height 12.5 cm) and allowed free access to food and water. For mouse groups transported to the 
fire grounds, the shoebox cage was wrapped in heat-resistant material, AB Technology Group 
Knitted Fiberglass Plain Tape (Ogdensburg, NY) and 3M Silver Foil Tape 3340 (Maplewood, 
Minnesota), on 3.5 sides to insulate from excessive heat and a Fisher Scientific (Hampton, NH) 
digital probe thermometer was placed in each cage. Mice were allowed a minimum of 24 hours 
to acclimate to cage environment. Housing temperature (72 °F) and humidity (45–55%) were 
controlled as was a 12/12 h reversed dark-light cycle (light = 1000-2200 h). Total number of 
mice being used was 72. 
 
Live-Fire Scenario and Overhaul Period- Firefighting activities were conducted in a 
purpose-built live-fire research test fixture. The house was designed by a residential architectural 
company to be representative of a home constructed in the mid-twentieth century with walls and 
doorways separating all of the rooms and 8 ft. ceilings. The house had an approximate floor area 
of 1200 ft2, with 4 bedrooms, 1 bathroom (closed off during experiments) and 8 total rooms.  The 
home was a wood frame, type 5 structure with a wood truss constructed roof. Interior finish in the 
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burn rooms were protected by ⅝” Type X gypsum board on the ceiling and ½” gypsum board on 
the walls. To maximize the use of the structure and minimize time between experiments the house 
was mirrored so that there were 2 bedrooms on each side where the fire would be ignited.  During 
each experiment a wall was constructed at the end of the hallway to isolate 2 bedrooms so that 
they could be repaired and readied for the next experiment.   
 
Furniture was acquired from a single source such that each room was nearly identical for 
each experiment. The bedrooms, where the fires were ignited, were furnished with a double bed 
(covered with a foam mattress topper, comforter and pillow), stuffed chair, side table, lamp, dresser 
and flat screen television.  The floors were covered with polyurethane foam padding and polyester 
carpet.  All other rooms of the structure were also furnished to provide obstacles for the firefighter, 
but those materials were not involved in the fire. Fires were ignited in the stuffed chair in both 
bedrooms using a remote ignition device comprising of a book of matches and electrically 
energized with a fine wire to heat the match heads, and create a small flaming ignition source.  The 
flaming fire was allowed to grow until it began to become ventilation limited and the fire 
department was dispatched.  The time of dispatch was between 4 minutes and 5 minutes after 
ignition for all 4 experiments.   
 
Teams of 12 firefighters completed different scenarios that included a fire involving 
multiple rooms with windows vented using two separate firefighting strategies: (a) traditional 
interior attack from the “unburned side” (advancement through the front door to extinguish the 
fire) and (b) transitional fire attack (water applied into the bedroom fires through an exterior 
window prior to advancing through the front door to extinguish the fire).  The teams were separated 
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into pairs that completed specific tasks. The first arriving complement of 4 firefighters was split 
into: Engine 1 – interior firefighters responsible for the attack line and exterior based command 
and pump operator positions. One minute later the second group of 4 firefighters arrived and was 
split into: Truck A – interior firefighters responsible for forcible entry into the structure as well as 
search and rescue and Truck B that conducted exterior ventilation (horizontal and vertical).  The 
last arriving complement of 4 firefighters was split up into initial exterior tasks that transitioned 
into overhaul.  Engine 2A pulled a back-up line and supported the first-in engine prior to overhaul 
operations.  Engine 2B initially set up as a rapid intervention team (RIT) then transitioned to 
overhaul operations after the fire was suppressed.  The Engine 2 crews began overhaul as soon as 
Engine 1 and Truck A completed their interior operations (i.e. fires were completely suppressed 
and victims removed).  The mouse cages were moved into the structure at the same time that the 
overhaul crews began their work.  
 
Mouse Groups/Transport/Housing- Mice were placed in three experimental groups: a 
control (C) group, which served as an in-house control staying in the animal care facility 
throughout fire ground activities; non-smoke (NS) group, which was taken to the fire grounds 
but placed on opposite end of fire acting as on-site control; smoke (S) group, which was taken to 
the fire grounds and placed in the interior of the post-fire structure. Within each group, the 
difference in tactical choice was compared between a traditional interior offensive attack (as 
denoted by 1) and transitional offensive attack (as denoted by 2). Mouse groups NS and S were 
transported from the animal care facility 30 minutes prior to the start of firefighting activities and 
brought back to the facility 15 minutes after the conclusion of overhaul activities.   
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Atmospheric Data Collection- Sampling media were connected to calibrated SKC Inc. 
AirChek® XR5000 and Pocket Pumps® sampling pumps (Eighty Four, PA) using polyvinyl 
chloride (PVC) tubing. Once overhaul commenced, the sampling media were inserted through a 
pre-drilled hole in the exterior of the bedroom and then the pumps were turned on to draw air 
from the bedroom through the media. The hole was 5 foot above the interior floor and 1 meter of 
where the mice were positioned. For monitoring hydrogen cyanide (HCN), we used soda lime 
SKC Inc. sorbent tubes 226-28 and ran the pumps at 200 cc/min. For monitoring polycyclic 
aromatic hydrocarbons (PAHs) in gas and solid phase, we used OSHA versatile samplers with 
glass fiber filter and OVS-XAD-7 sorbent SKC Inc. 226-57 and ran the pumps at 1 L/min. For 
monitoring inorganic acid gases, we used washed Sigma Aldrich 20265 silica gel tubes (St. 
Louis, MO) and ran the pumps at 0.5 L/min. After sampling, the media were capped and stored 
at -20 °C until analysis. For monitoring benzene, we collected air using 500 mL evacuated 
Entech Instruments Bottle-Vac™ samplers (Simi Valley, CA). A regulator with frit filter was 
attached to the inlet of the sampler to allow for a constant collection rate of air (~33 mL/min). 
Clean PVC tubing was connected to the inlet of the regulator and inserted into the bedroom. 
Sampling proceeded over the overhaul period, at which point, the pressure inside the bottle had 
nearly reached atmospheric and the regulator was removed. The soda lime sorbent tubes were 
analyzed for HCN using NIOSH Method 6017 (NIOSH 2013). Concentrations were calculated 
using the mass of contaminant measured divided by the volume of air collected or passed 
through the sampling media during the sampling period. 
 
RNA extraction and Fragment analysis- Mouse lung tissue was extracted two hours post-
exposure to the overhaul period and immediately placed in Qiagen RNAlater RNA stabilization 
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reagent (Valencia, CA). Lung tissue RNA was extracted using the Qiagen miRNeasy Mini Kit 
including DNAase to purify total RNA for sequencing analysis. In order to determine the RNA 
integrity number (RQN), samples were run on Applied Biosystems Fragment analyzer (Foster 
City, CA).  All samples except for two (one in-house control and non-smoke control) had 
acceptable RQN scores above the threshold >7 and were subsequently sequenced.  
 
Illumina RNA sequencing- 70 samples of RNA containing the three treatment groups and 
two tactical choices were used to construct 70 RNAseq libraries of eukaryotic RNA prepared 
with Illumina TruSeq Stranded RNA Sample Prep Kit (San Diego, CA) resulting in 5’ to 3’ 
strand-specific libraries. All libraries were pooled and quantitated by qPCR and sequenced on 
seven lanes for 101 cycles using an Illumina HiSeq2500 100nt single-end read with the TruSeq 
SBS sequencing v3 kit. Fastq files were processed and demultiplexed with bcltofastq 1.8.4.   
 
RNAseq Data Analysis- RNAseq data pre-processing and statistical analyses were done in 
R (v. 3.2.2) using the limma package (v 3.26.0) unless stated otherwise. The 70 samples out of 
the initial 72 that reached appropriate RQN criteria were pre-processed by initially uploading and 
reference genome converted to GTF using rtracklayer (v 3.2.0) for later downstream alignment 
using STAR program. Samples consisted of N = 11-12 for all groups represented. Raw data was 
checked for quality using FASTQC (v 0.11.2). After reads were checked for quality, trimming 
and filtering of the raw reads followed by using Trimmomatic (v 0.33) to trim residual adapter 
content and low quality bases. Trimmed reads were checked for quality similar to the raw reads 
by use of FASTQC (v 0.11.2) on the trimmed and filtered reads. Trimmed and filtered reads 
were aligned using STAR (v 2.4.2a) software by creating an initial STAR index of the combined 
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reference genome then aligning the reads directly to the combined reference genome. Post-
alignment the gene counts were determined using featureCounts (v 1.4.3-pl) with multi-mapping 
reads being excluded. Following pre-processing, trimmed/filtered and aligned gene counts were 
prepared for R statistical analysis. Gene counts were normalized to get an effective library size 
by using the TMM normalization (Robinson and Oshlack 2010) method in the edgeR package 
(Robinson et al. 2010). Normalized and filtered samples were clustered using hierarchical 
clustering via Euclidean distances to determine possible outliers and overall treatment 
differences (Figure 4.1). Three outliers were removed (NS.2.441, C.2.231, and NS.1.601) for 
principle component analysis using a Surrogate Variable Analysis (Leek and Storey 2008; Leek 
and Storey 2007) by means of the sva package (Leek et al. 2012). SVA packge run on log2-
transformed CPM values with 9 surrogate variables detected. The surrogate variables were added 
to the statistical model for the 6 treatments x tactical groups and differential expression testing 
(Smyth 2004) using the limma package (Ritchie et al. 2015) and the voom function (Law et al. 
2014). One-way analysis of variance (ANOVA) testing was used across the 6 groups was 
calculated accompanied with appropriate pairwise comparisons. Interaction tests were performed 
between the S vs. NS groups difference for interior vs. transitional tactical choices. Multiple 
hypothesis testing adjustment was performed for each statistical test using the False Discovery 
Rate method (Benjamini and Hochberg 1995). Heat map was generated for the significant gene 
expression for smoke vs non-smoke groups during interior attack to determine expression 
patterns across all 6 groups (Figure 4.4). Functional annotation taken from Bioconductor’s 
(Huber et al. 2015) org.Mm.eg.db package (Carlson 2015) using the Entrez Gene ID given for 
each gene in NCBI ref_GRCm38.p3_top_level.gtf file. Updated pathways taken from KEGG 
using the KEGGREST package (Tenenbaum 2015). Over-representation testing was done on 
62 
 
KEGG pathways and GO terms using the GOstats (Falcon and Gentleman 2007) and Category 
(Gentlman et al. 2015) package done separately for the purple and black gene sets identified 
from the heatmap (Figure 4.4). All pathways were evaluated with an FDR adjustment for raw p-
values < 0.005 to determine significance. Pathway maps for each gene set generated using the 
pathview (Luo and Brouwer 2013). Statistical significance was assumed at p < 0.05 unless 
otherwise noted. 
Results 
In-House Control (C), Non-Smoke (NS), and Smoke (S) samples evaluated for global 
transcription profile, principle component analysis (PCA), and hierarchical clustering between 
interior and transitional attack. To determine the transcriptomic relationship between control, 
non-smoke, and smoke treatment groups when exposed to overhaul environment of a modern 
live-fire scenario using multiple tactical choices, a high-throughput sequencing analysis was used 
to understand downstream global gene expression. Table 4.1 identifies the total number of gene 
entities making up the sequenced reads with the amount of 41786 but only 15935, a reduction of 
62%, being analyzed for differential expression across all samples post-filtering. Figure 4.1 
shows the normalized samples clustered in order to comprehend any outliers or overall treatment 
differences observed by groupings clustering either farther or closer together. Based on the data, 
only three data points including NS.2.441, C.2.231 and NS.1.601 were determined to be outliers 
due to breaking off the hierarchy initially, indicating differences from the other samples. The 
clustering grossly shows C groups, both of interior (1) and transitional (2) technique, cluster 
farthest left with both NS groups intermixed along the center with largely S.2 represented within 
this grouping. The cluster of S.1 samples were grouped farthest to right showing these samples 
as least similar to the C and NS groups as expected. An additional evaluation of overall treatment 
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differences was conducted  amongst the normalized gene expression data by means of a principal 
component analysis (PCA) using Surrogate Variable Analysis (Leek and Storey 2008; Leek and 
Storey 2007), used to recognize the obvious variations in data presented as principal components 
(Ringnér 2008). Based on the data presented in Figure 4.2, it is apparent to conclude distinct 
differences between all three treatment groups of C, NS, and S. The analysis shows a similar 
variation difference between the C group compared to both NS and S groups demonstrating a 
likely stress effect within treatment groups. PCA indicated that tactical choice showed variation 
within both NS and S treatments with NS.2 and S.2 largely intermixed but NS.1 and S.1 show 
largest variation differences within group.  
 
Transitional attack reduces overhaul temperature without large-scale changes in other 
environmental contaminants when compared to an interior attack in a modern live-fire scenario. 
In order to conclude the atmospheric conditions impacting differential expression seen in lung 
tissues during overhaul activity, measurement of the environment was conducted and analyzed. 
Table 4.2 showed a 10%, 12%, and 18% reduction in average temperature, average hydrogen 
sulfide (H2S), and maximum H2S, respectively, during overhaul when transitional attack was 
deployed compared to an interior attack. However, the transitional attack exhibited slightly 
increased average levels of hydrogen cyanide (HCN), carbon monoxide (CO), and oxygen (O2) 
by 169%, 21%, and 0.2%, respectively. These values correlated similarly with maximum HCN, 
maximum CO, and minimum O2 levels with increases of 111%, 46%, and 0.5%, respectively. 
The levels of carbon dioxide (CO2) were left unchanged based on tactical choice during the 
overhaul period. 
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Lung tissue of Smoke samples during interior attack show drastically increased 
differential expression with reduced gene expression in samples after a transitional attack during 
overhaul exposure. Differential gene expression within treatments was assessed in order to 
highlight significant genes as likely candidates for influencing health effects in lung tissues after 
exposure during overhaul operations. Table 4.3 identified the overall number of significantly 
expressed genes, both up and down regulated, across combinations of treatment groups with a 
FDR raw p-value < 0.05 and a log2 fold change (FC). C.1 compared to C.2 showed minimal 
difference in gene expression, however, when C.1 was compared to both NS.1 and S.1 groups 
showed extreme increases in gene expression, totaling 3919 and 5391 respectively. Increased 
values are expected due to the transport stress placed on NS and S groups in transport to and 
from the fire ground. Interestingly, a 38% increased difference between NS.1 and S.1 groups was 
observed when compared to controls. NS.1 compared to NS.2 groups level of gene expression 
included 1099 genes represented by 561 up-regulated and 538 down-regulated genes. Most 
importantly, NS.1 versus S.1 showed relatively high levels of significant expression, total of 
2666 up and down regulated genes, whereas NS.2 versus S.2 level of significantly expressed 
genes signified only a dismal total of 60 genes, representing a reduction of 98%.  
 
Table 4.4 lists the differentially expressed genes with a FDR raw p-value < 0.05 and log2 
FC of ± 1.5 in S.1 group compared to the NS.1 group in detail. The list of genes consists of 26 
up-regulated and 90 down-regulated genes of significant difference for a total of 116. S.1 shows 
drastic changes in gene expression, importantly 4 of the top 5 up-regulated genes show links to 
cancer or immunological inhibition, specifically calpain 11 (Capn11), immunoglobulin kappa 
chain variable 5-43 (Igkv5-43), RAR-related orphan receptor gamma (Rorc), and noggin (Nog) 
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(Huang and Wang 2001; Iacovelli et al. 2015; Tosolini et al. 2011; Tarragona et al. 2012). 
Inversely, several down-regulated genes are responsible for proper immune response and cancer 
defense, especially nuclear receptor subfamily 1 Group D member 1 (Nr1d1), spondin 2 
extracellular matrix protein (Spon2), tumor necrosis factor receptor superfamily member 13c 
(Tnfrsf13c), S100 calcium binding protein A9 (S100a9) and S100 calcium binding protein A8 
(S100a8) (Vasu et al. 2009; Manda et al. 2000; Gioia-Losi et al. 2005; Su et al. 2010).  
 
Conversely, Table 4.5 displays an impressively low level of gene expression in S.2 
compared to NS.2 demonstrating transitional attack during overhaul period reduces differential 
expression. Values were assessed for significance via FDR raw p-value < 0.05 and log2 FC of ± 
1.5. The list contains 1 up-regulated and 2 down-regulated genes for 3 total significant 
differences between S.2 and NS.2 groups. Similarly to Table 4.4, the significantly expressed 
genes demonstrate important properties in immunology and cancer, however, genes in Table 4.5 
FC trends appropriately to mitigate cancer risks including up-regulated gene of chemokine (C-X-
C motif) receptor 1 (Cxcr1) (Ginestier et al. 2010) and down-regulated genes retinoic acid 
receptor beta (Rarb) or hyperpolarization-activated cyclic nucleotide-gated K+ 1 (Hcn1) (Houle 
et al. 1991; Collettii II et al. 2014). 
 
Table 4.6 shows the significant genes comparing S.2 to S.1 treatment groups with FDR 
raw p-value < 0.05 and log2 FC of ± 1.5 signifying the differentially expressed genes of smoke 
treated animals between transitional and interior tactical choices during overhaul period. Total of 
9 genes met threshold with 3 up-regulated and 6 down-regulated. Within the differentially 
expressed genes, several up-regulated genes showed importance in immunological functioning, 
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especially chemokine (C-C motif) receptor 9 (Ccr9) and tumor necrosis factor (ligand) 
superfamily member 9 (Tnfsf9) (Uehara et al. 2002; Grimm 2016). Down-regulated genes 
established more concerning cancer-related genes in an interior attack compared to a transitional 
attack, as signified by metastasis associated lung adenocarcinoma transcript 1 (Malat1), ATP-
binding cassette sub-family A (ABC1) member 13 (Abca13), and zinc finger and BTB domain 
containing 20 (Zbtb20) genes respectively (Pang et al. 2015; Nymoen et al. 2015; Wang et al. 
2011). 
 
Representative global gene expression patterns between Smoke and Non-Smoke samples 
during exposure to overhaul conditions after an interior attack.  In assessing the impact of 
current firefighting techniques during overhaul impact on global gene expression, a heatmap 
were constructed using differentially significant genes amongst the S and NS groups after an 
interior attack to assess expression patterns across all six groups. The S.1 and NS.1 groups were 
chosen for heatmap construction due to largest amount of differentially expressed genes between 
S and NS groups, totaling 2666 genes, as evidenced by Table 4.3. The 2666 genes from the S.1 
and NS.1 groups were assessed for expression pattern by one-way ANOVA across all six groups 
with a false-discovery (FDR) level of p < 0.05. Based on Figure 4.3, two main expression 
patterns were apparent depending on the respective treatment differences. One expression pattern 
determined by the heatmap show large similarities in the C and NS groups when compared to the 
S group for the genes located in the purple and black bars (n genes = 1058 and 741, 
respectively). Last expression pattern for Figure 4.3 shows the C and S groups similarly but 
different from the NS groups within the yellow and green bars (n genes = 327 and 540, 
respectively). 
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KEGG over-representation testing amongst Smoke samples after an interior attack show 
important immunological and disease pathways associated with overhaul exposure. Over-
representation analysis is an important tool in determining crucial pathways central to disease 
understanding (Jin et al. 2014). Therefore, all pathways in samples that were exposed during 
overhaul after an interior attack (S.1), including the genes in black and purple clusters of Figure 
4.3, were analyzed for over-representation based on KEGG (Kyoto Encyclopedia of Genes and 
Genomes) database with important pathways having more significant genes than expected due to 
chance. Figure 4.4 shows the 32 pathways that were determined to be significant with FDR-
adjusted raw p-value < 0.005 across all three clusters, black, purple or both. In addition, the 
figure shows significance with a red scale of –log10(p-value) and actual p-value printed within 
respective pathway box. Grey boxes were shown with no p-values due to no genes for that 
particular list mapped to the pathway. Within the black cluster, a total of 13 of the 32 (41%) 
pathways examined were found to be significantly over-represented and the purple cluster 
contained 26 out of 32 (81%) pathways over-represented within respective samples. 
Discussion 
Firefighting activity is commonly associated with multiple acute, as well as prolonged 
disorders, including but not limited to cancer (Sama et al. 1990; Daniels et al. 2013), 
cardiovascular (Soteriades et al. 2011; Kales et al. 2007) and respiratory disease (Sheppard et al. 
1986; Scannell and Balmes 1995), and psychological stress (Guidotti 1992). Initiation of these 
disease conditions is canonically thought to be related to contaminant exposure during all periods 
of fire suppression activity including both attack and overhaul phases (Bolstad-Johnson et al. 
2000; Fritschi and Glass 2014). But little information is available regarding the identification of 
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specific genes underlying these disease pathways and their ability to impact first responders or 
the phases associated with the greatest risks. Therefore, assessment of gene associated 
differences between an interior (1) versus a transitional (2) tactical choice after overhaul 
exposure for relative predictors of future disease is critical. In general, the data show similar 
groupings for both the control (C) and non-smoke (NS) groups. With the greatest differences 
observed within the exposed smoke (S) group (Fig. 2). In addition, Fig. 4.1 demonstrates in 
greater detail the relationships between the three respective groups and tactical choice by 
grouping NS and C groups closer together with both intermixed for interior and transitional 
tactics. Similar to Fig. 4.2, the smoke group, specifically the interior tactical choice (S.1), 
showed the greatest differences with the smoke groups after transitional tactics (samples furthest 
to the right) being the most different from the other samples. These results support the original 
hypothesis indicating S exposed samples during overhaul are significantly differentiated from 
NS and C groups and that transitional attack shows promise in mitigating the differentiation 
observed. 
 
Importantly, only an overhaul exposure total of fifteen minutes following a live-fire 
scenario following a standard interior tactical choice (NS.1 vs S.1) substantially increased gene 
expression levels in the lungs of respective mouse cohorts (Table 4.3). This robust gene 
expression response to overhaul exposure is expected based on the understanding that 
environmental contaminants, such as poly-aromatic hydrocarbons (PAH), can similarly produce 
a significant immune and inflammatory response (Burchiel and Luster 2000). These data 
represent a confirmation of prior literature indicating overhaul as a significant contributor to 
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cancer risk amongst firefighters in the line-of-duty (Guidotti and Clough 1992; Burgess et al. 
2001). 
 
Table 4.4 illustrates the significant immune and inflammatory response evidenced during 
the overhaul phase after an interior tactical choice. More specifically, the list of differentially 
expressed genes in Table 4.4 indicates an aberrant immune response after a sufficient challenge 
during overhaul, likely via contaminant induced-hypoxia. Important down-regulated genes 
representing the observed insufficient immune response included Nuclear Receptor Subfamily 1 
group D member 1 (Nr1d1), Immunoglobulin Kappa Chain Variable 19-93 (Igkv19-93), Spondin 
2 (Spon2), Tumor Necrosis Factor Receptor Superfamily member 13c (Tnfrsf13c), and both 
S100 calcium binding protein A8 and A9 (calgranulin A and B) (S100a8 and S100a9). 
Supplementary evidence for a suppressed response after an interior tactical choice was the lack 
of a classical pro-inflammatory response, such as IL-1, TNF-alpha, and IL-6 (Walters et al. 
2013), with the down-regulation of genes such as Interleukin-1 Beta (Il1b), Interleukin-1 
Receptor type II (Il1r2), and Tumor Necrosis Factor superfamily member 9 (Tnfsf9) (Table 4). In 
coordination with this response, Table 4.4 shows an increased level of cancer-associated genes 
including Calpain 11 (Capn11), RAR-Related Orphan Receptor Gamma (Rorc), Noggin (Nog), 
and Deoxyribonuclease II Beta (Dnase2b) (Huang and Wang 2001; Tosolini et al. 2011; 
Haudenschild et al. 2004; Ribeiro et al. 2011).  
Additionally, Fig. 4.3 visually identifies the risks associated with the overhaul phase after 
an interior tactic as evidenced by the largely direct opposite colors within NS.1 columns 
compared to the S.1 columns. Within the differentially expressed genes identified in Fig. 4.3, a 
number of important pathways were identified as significantly over-represented (Fig. 4.4) 
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including Rap1 signaling pathway, natural killer cell mediated cytotoxicity, asthma, 
proteoglycans in cancer, and cytokine-cytokine receptor interaction amongst others. These 
associated results were expected, as previous literature has identified certain disease conditions 
with firefighting activity such as increased asthma prevalence (Ribeiro et al. 2008) and cytokine 
interactions in declining lung function (Berran et al. 2008). Thus, overhaul exposure after an 
interior tactical choice leads to a deficient immune response within the lungs while increasing 
cancer-related genes resulting in an environment sufficient for acute and long-term diseases. 
  
In contrast, overhaul exposure after a transitional attack shows minimal gene expression 
profile response as shown in Table 4.5. The transitional tactical choice significant differentially 
expressed genes possess the ability to mount an appropriate immune response to the overhaul 
challenge with up-regulation of pro-immune Chemokine (C-X-C motif) Receptor 1 (Cxcr1) 
(Sallusto 2002) and down-regulation of cancer-associated genes such as Retinoic Acid Receptor 
Beta (Rarb) (Houle et al. 1991) and Hyperpolarization-Activated Cyclic Nucleotide-Gated K+ 1 
(Hcn1) (Hicks et al. 2011). Arguably, more important than gene set identification is determining 
efficacious and preventative treatments, that if enacted could result in drastic reduction of the 
risks associated with firefighting activity. Table 4.3 shows a dramatic reduction in significantly 
expressed genes from interior to transitional tactical choice with approximately a 98% reduction 
(2666 vs 60). Correspondingly, difference in tactical choice resulted in a decrease in average 
environmental temperature of 10.3% suggesting that transitional attack results in a less harmful 
environment minimizing risk when exposed during overhaul. This result is similar to Schwarz 
and Wheeler where they showed a traditional attack drastically reducing floor temperature with 
minimal redeveloping fire as well as keeping sufficient thermal balance.  
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Transitional tactical choice shows an increased immune response compared to interior 
(S.2 vs S.1) as shown in Table 4.6 with the up-regulation of pro-immune associated genes such 
as Chemokine (C-C Motif) Receptor 9 (Ccr9) (Svensson and Agace 2006) and Tumor Necrosis 
Factor Superfamily Member 9 (Tnfsf9) (Collette et al. 2003). Also, Table 6 showed down-
regulation of cancer-associated genes such as Metastasis Associated Lung Adenocarcinoma 
Transcript 1 (Malat1) (Gutschner et al. 2013), ATP-Binding Cassette Sub-Family A Member 13 
(Abca13) (Hlavata et al. 2012), and Zinc Finger and BTB Domain Containing 20 (Zbtb20) 
(Wang et al. 2011). These results add sufficient evidence to suggest that a transitional tactical 
choice compared to interior during overhaul positively impacts fireground environmental change 
resulting in greater pro-immune and anti-cancer gene expression profiles. 
 
In summary, short exposure to the overhaul phase following a live-fire scenario results in 
robust increase in differentially expressed genes after a traditional interior tactical decision. The 
increased gene expression associated with an aberrant and possibly insufficient immune response 
whilst supporting a pro-cancer environment. These results add to supporting evidence identifying 
overhaul as a key risk to cancer incidence amongst firefighters. Also, a transitional tactical 
choice appears to reduce the immune and cancer-associated risk by decreasing overall gene 
expression as well as corresponding decline in environmental temperature during overhaul in 
comparison to interior. This study supports the concept of deploying a transitional tactical attack 
when applicable in order to reduce the short- and long-term health risks associated with 
firefighting activities. 
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FIGURES AND TABLES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Hypoxia/reoxygenation results in elevated caspase-1 activity in the amygdala 
but not the hippocampus. Wild-type mice were exposed to hypoxia and following 2 hrs 
reoxygenation were evaluated for caspase-1 activation. Localized brain sections were taken and 
caspase-1 activity determined via immunohistochemical analysis. (A) Representative images of 
caspase-1 activation of the amygdala and hippocampus for both normoxic (Norm) and hypoxic 
(Hyp) treatment. (B) Area of staining (% Control) for mice following normoxia and hypoxia in 
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Figure 2.1 (cont.) the amygdala and hippocampus were measured for Biotin-YVA-CMK using 
imageJ. Results are expressed as means ± SEM.; n = 6-11, values with an asterisk are significant 
at p < 0.05, using Mann-Whitney Rank Sum Test. 
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Figure 2.2 (cont.). Glyburide and DMPX (A2A AR antagonist) reduces caspase-1 
activity induced by hypoxia/reoxygenation. Wild-type mice were injected with either glyburide 
or DMPX prior to 2 hr hypoxia exposure. (A) Glyburide reduces hypoxia-induced caspase-1 
activation in the amygdala with no apparent changes in the hippocampus (B) based on area of 
staining (% Control). (C&D) Representative images of caspase-1 activation within the amygdala 
and hippocampus following hypoxia (Hyp) with either saline (Sal) or glyburide (Gly) treatment. 
(E) DMPX reduces hypoxia-induced caspase-1 activation in the amygdala without impacting 
levels of activity in the hippocampus (F) based on area of staining (% Control). (G&H) 
Representative images of caspase-1 activation within the amygdala and hippocampus following 
hypoxia with either saline or DMXP treatment. Results expressed as means ± SEM.; n = 3-4, 
values without a common subscript are different (a vs b, p < 0.05) with (A&B) and (E&F) 
analyzed using 2-way analysis of variance (ANOVA). 
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Figure 2.3. Glyburide and DMPX improved NOR memory recall following 
hypoxia/reoxygenation. Wild-type mice were administered either glyburide (Gly) or DMPX with 
saline (Sal) controls prior to hypoxia and tested for memory recall via NOR 1 hr following 
hypoxic exposure. (A) Glyburide administration prior to hypoxia restores NOR memory recall 1 
hr post-hypoxia compared to Sal controls. (B) DMPX administration prior to hypoxia restores 
NOR memory recall 1 hr post-hypoxia compared to Sal controls. Discrimination index was 
defined as time spent exploring novelty divided by time spent investigating both objects. Results 
are expressed as means ± SEM.; n = 3-8, values without a common subscript are different (a vs 
b, p < 0.05) with (A) and (B) analyzed using 2-way analysis of variance (ANOVA). 
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Figure 2.4. Majority of caspase-1 activity in the amygdala following 
hypoxia/reoxygenation induced by neurons. Wild-type mice were exposed to hypoxia and 
allowed to reoxygenate for 2 hrs when amygdala sections were harvested and stained for active 
caspase-1 activity and neuron-specific enolase (NSE) via immunohistochemistry. (A) Hypoxic 
mice showed significantly increased level of co-localization (number of NSE-caspase-1 labeled 
cells/total number of caspase-1 labeled cells) compared to normoxic mice. (B&C) Representative 
images of caspase-1 activation within the amygdala following normoxic or hypoxic treatment, 
respectively. Results are expressed as means ± SEM.; n = 2-3, values with an asterisk are 
different (a vs b, p < 0.05) with (A) using 1-way analysis of variance (ANOVA). 
  
  
0
20
40
60
80
100
Norm
%
 C
o-
Lo
ca
liz
at
io
n 
(C
as
pa
se
-1
/N
eu
ro
ns
)
Amygdala
Norm
Hyp
Normoxic Hypoxic 
A 
B C 
* 
77 
 
0
50
100
150
200
250
Norm Hyp
Ar
ea
 (%
 C
on
tr
ol
)
Amgydala
NCRE
IGF1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. Neuronal knockout of IGF-I reduces hypoxia-induced caspase-1 activity and 
restores memory recall via NOR performance. NCreE+/+ (NCRE) and N-CreE-IGF-I flox/flox 
(IGF1) mice were exposed to hypoxia for 2 hours and evaluated for caspase-1 activity and NOR 
performance following reoxygenation. (A) Knocking out neuronal-IGF-I (IGF1) reduces     
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Figure 2.5 (cont.) hypoxia-induced caspase-1 activation in the amygdala with no observed 
changes in the hippocampus (B) based on area of staining (% Control). (C&D) Representative 
images of caspase-1 activation within the amygdala and hippocampus following hypoxia (Hyp) 
with either NCRE or IGF1 genotypes. (E) IGF1 knockout mice recovered NOR memory recall 1 
hr post-hypoxia when compared to NCRE control. Discrimination index was defined as time 
spent exploring novelty divided by time spent investigating both objects. Results are expressed 
as means ± SEM.; n = 2-11, values without a common subscript or asterisk are different (a vs b, 
p < 0.05) with (A) and (B) analyzed using 2-way analysis of variance (ANOVA) and (E) using 1-
way analysis of variance (ANOVA). 
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Figure 2.6. Phosphorylated IRS-1 and p70SK significantly increased following 
hypoxia/reoxygenation but no change in IGF-I, cAMP, and PKA. Wild-type mice were exposed 
to hypoxia and allowed to reoxygenate for analysis of phosphorylated genes, IGF-I, cAMP, and 
PKA. (A) Following 1 hr of reoxygenation, p-IRS-1 and p-p70SK were significantly increased 
following hypoxia. IGF-I concentrations within the amygdala or hippocampus showed no 
differences whether exposed to hypoxia/reoxygenation (B) or adenosine (C) administration. No 
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Figure 2.6 (cont.) differences were observed in PKA activity (D) or cAMP activity (E) within 
the amygdala or hippocampus following hypoxia. Results are expressed as means ± SEM.; n = 3-
9, values with an asterisk are significant at p < 0.05, using one-way analysis of variance 
(ANOVA). 
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Table 3.1 
Body weight (g), blood glucose (mg/dL), plasma NEFA (mEq/L), food intake (g/d), and 
energy intake (kcal/g/d) of mice fed a LFD or HFD 
 
Time on diet 
1 wk 3 wk 6 wk 
Diet LFD HFD LFD HFD LFD HFD 
Body 
Wt 
17.9 ± 
0.4a 
19.3 ± 
0.9b 
20.9 ± 
0.4a 
23.7 ± 
0.5b 
22.5 ± 
0.5a 
28.9 ± 
0.5b 
FBG 129.9 
± 8.2 
164.1 ± 
17.8 
144.0 ± 
10.1a 
187.1 ± 
6.9b 
146.3 ± 
16.2a 
208.0 
± 16.0b 
Plasma 
NEFA  
0.784 
± 0.03 
0.662 ± 
0.23 
0.633 ± 
0.06 
0.742 ± 
0.04 
0.638 ± 
0.87 
0.839 
± 0.10 
Food 
Intake  
3.20 ± 
0.6 
3.23 ± 
0.08 
3.17 ± 
0.17 
2.98 ± 
0.15 
3.42 ± 
0.7 
2.88 ± 
0.12 
Energy 
Intake  
12.31 
± 
0.18a 
16.92 ± 
0.41b 
12.21 ± 
0.18a 
15.59 ± 
0.41b 
13.2 ± 
0.18a 
15.1 ± 
0.41b 
Results are expressed as mean ± SEM, n=4-30 per group. One-way ANOVA revealed main 
effect of diet (P<0.05).  
 
Letters within rows indicate significant differences. 
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Table 3.2 Impact of LFD or HFD feeding on gene expression in the hippocampus and amygdal  
after 3 wks of feeding. 
  Amygdala   Hippocampus  
Gene LFD HFD LFD HFD 
Arc3.1 1.000 ± 0.140 
0.759 ± 
0.436 
1.000 ± 
0.250 0.751 ± 0.216 
iNOS 1.000 ± 0.157 
0.783 ± 
0.147 
1.000 ± 
0.177a 1.993 ± 0.314
b 
eNOS 1.000 ± 0.087 
0.965 ± 
0.144 
1.000 ± 
0.119 1.277 ± 0.088 
IL1-R2 1.000 ± 0.124 
0.879 ± 
0.316 
1.000 ± 
0.103 0.981 ± 0.201 
Casp1 1.000 ± 0.035 
0.856 ± 
0.152 
1.000 ± 
0.152 0.936 ± 0.068 
TXNIP 1.000 ± 0.108 
1.075 ± 
0.034 
1.000 ± 
0.196 0.996 ± 0.158 
SOD1 1.000 ± 0.121 
0.811 ± 
0.044 
1.000 ± 
0.126 1.114 ± 0.080 
BDNF 1.000 ± 0.112 
1.333 ± 
0.130 
1.000 ± 
0.168 1.092 ± 0.246 
Results are expressed as relative fold change in mRNA expression (mRNA), means ± SEM.; n =  
Results within individual rows without a common superscript letter are significantly different. 
Letters within rows indicate significant main effect of diet. 
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Figure 3.1. High-fat diet mice develop object memory impairment and transient anxiety-
like behaviors. HFD-mice (HFD), LFD-mice (LFD)-, and/or standard chow-mice (SC) 
underwent novel object recognition at the times indicated (NOR) (A), and at one week after diet 
(B). HFD-mice (HFD) and LFD-mice (LFD) underwent object location recognition (OLR) 
testing at the times indicated (C). Total time spent investigating both novel and familiar objects 
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Figure 3.1 (cont.) were determined for NOR (D) and OLR (E). HFD-mice and LFD-mice were 
examined using elevated zero maze (EZM) (F) and the open field test (OFT) (G). Discrimination 
index for NOR and OLR was defined as time spent exploring novelty divided by time spent 
investigating both objects. All results are expressed as means ± SEM.; n = 4-16, values with an 
asterisk are significant at p < 0.05, using one-sample t-test with novel object preference 
compared with chance level of 0.5 and 1-way analysis of variance (ANOVA).  
 
 
 
 
 
 
 
Figure 3.2. The GSH:GSSG ratio in the amygdala and hippocampus is reduced by a 
HFD. Glutathione (GSH) and glutathione disulfide (GSSG) were measured in high-fat diet- 
(HFD) and low-fat diet (LFD)-mice and presented as GSH:GSSG in both the amygdala (A) and 
hippocampus (B). GSH:GSSG ratios in amygdala and hippocampus of HFD-mice injected with 
glyburide (C). Results                                                                                                                 
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Figure 3.2 (cont.) are expressed as means ± SEM, n = 5-10, values with an asterisk are 
significant, p < 0.05 using Kruskal-Wallis 1-way analysis of variance (ANOVA) on Ranks. 
 
Figure 3.3. Glyburide reduces anxiety-like behaviors associated with a HFD after 3 wks 
of diet. High-fat diet- (HFD) and low-fat diet (LFD)-mice were administered either saline or 
glyburide and examined after 4 hrs in an elevated zero maze (EZM). Time in the open (A) and 
closed arms (B) are presented. Similarly treated HFD- and LFD-mice were examined for 
locomotion (C), and post-behavior blood glucose (D). All results are expressed as mean ± SEM.; 
n = 10-18, values without a common subscript or asterisk are different (a vs b, p < 0.05) with (A) 
and (B) analyzed using 1-way ANOVA and (C) and (D) using 2-way analysis of variance 
(ANOVA). 
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Figure 3.4.  Memory is improved by glyburide in HFD-mice after 3 wks of diet. High-fat 
diet- (HFD) and low-fat diet (LFD)-mice were administered either saline or glyburide after a 1 
wk of diet and examined using novel object recognition (NOR) testing (A). HFD- and LFD-mice 
were administered either saline or glyburide after a 3 wks of diet and examined using NOR (B) 
and OLR (C) testing. HFD and LFD mice were administered either saline or glyburide after a 6 
wks of diet and examined using OLR (D) testing. Discrimination index was defined as time spent 
exploring novelty divided by time spent investigating both objects. Results are expressed as 
means ± SEM.; n = 4-6, values with an asterisk are significant at p<0.05, using one-sample t-test 
with novel object preference compared with chance level of 0.5. 
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Table 4.1. Number of different gene entities in NCBI Mus musculus GRCm38.p3 gene 
annotations 
Entity Type Number in Genome Number After Filtering 
mRNA 21198 13610 
ncRNA 12285 1215 
Exon 4008 124 
Misc_RNA 1988 909 
Precursor_RNA 1187 16 
V_segment 535 39 
tRNA 413 7 
J_segment 94 0 
rRNA 35 2 
D_segment 23 0 
C_region 20 13 
Total 41786 15935 
 
Table 4.2. Environmental measurements of modern live-fire scenario between tactical choices 
Measure Tactical Choice 
 Interior Transitional 
Average Temperature (F) 94.50 084.80 
Average HCN (ppm) 00.26 000.70 
Max HCN (ppm) 01.40 002.95 
Average H2S (ppm) 00.25 000.22 
Max H2S (ppm) 02.45 002.00 
Average CO (ppm) 31.30 037.80 
Max CO (ppm) 80.50 117.50 
Average O2 (%) 20.80 020.85 
Min O2 (%) 20.55 020.65 
Average CO2 (%) 00.02 000.02 
Max CO2 (%) 00.07 000.07 
Measurements are based on means between multiple days respective of tactical choice.  
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Table 4.4. List of significant differentially expressed genes in S.1 vs NS.1 
Gene Symbol Entrez ID Gene Name Fold Change 
Capn11 268958 calpain 11  6.70 
Igkv5-43 381783 immunoglobulin kappa chain variable 5-43  3.43 
Igha 238447 immunoglobulin heavy constant alpha  2.30 
Rorc 19885 RAR-related orphan receptor gamma  2.27 
Nog 18121 noggin  2.24 
Dnase2b 56629 deoxyribonuclease II beta  2.12 
Eppin 75526 epididymal peptidase inhibitor  1.89 
Gkn3 68888 gastrokine 3  1.78 
Nav3 260315 neuron navigator 3  1.75 
Gal3st3 545276 galactose-3-O-sulfotransferase 3  1.73 
Scn2b 72821 sodium channel, voltage-gated, type II, beta  1.72 
Rasd1 19416 RAS, dexamethasone-induced 1  1.70 
Slc22a13b-ps 109280 
solute carrier family 22 (organic cation transporter), member 
13b, pseudogene  1.69 
Ajap1 230959 adherens junction associated protein 1  1.69 
Pcdh20 219257 protocadherin 20  1.63 
Ryr3 20192 ryanodine receptor 3  1.63 
Table 4.3. Number of genes significantly up- or down- regulated (FDR p-value < 0.05) 
between treatment groups 
Treatment Up Down Total 
C1 vs C2 134 111 245 
C1 vs NS1 2090 1829 3919 
C1 vs S1 2752 2639 5391 
NS1 vs NS2 561 538 1099 
NS1 vs S1 1281 1385 2666 
NS2 vs S2 30 30 60 
S1 vs S2 58 136 194 
Interact 56 73 129 
Significantly expressed genes shown relatively with first treatment compared to second treatment listed.  
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Abhd12b 100504285 abhydrolase domain containing 12B  1.60 
Kcnip3 56461 Kv channel interacting protein 3, calsenilin  1.59 
Sdk2 237979 sidekick homolog 2 (chicken)  1.58 
Zfp663 381405 zinc finger protein 663  1.57 
Lonrf3 74365 LON peptidase N-terminal domain and ring finger 3  1.56 
Upp2 76654 uridine phosphorylase 2  1.55 
Gpr179 217143 G protein-coupled receptor 179  1.55 
Ddit4 74747 DNA-damage-inducible transcript 4  1.52 
Per2 18627 period circadian clock 2  1.52 
Khdc3 66991 KH domain containing 3, subcortical maternal complex member  1.51 
Camkk1 55984 calcium/calmodulin-dependent protein kinase kinase 1, alpha -1.50 
Il1b 16176 interleukin 1 beta -1.50 
Sytl3 83672 synaptotagmin-like 3 -1.50 
Prokr1 58182 prokineticin receptor 1 -1.51 
Tmem108 81907 transmembrane protein 108 -1.51 
Atp1a3 232975 ATPase, Na+/K+ transporting, alpha 3 polypeptide -1.51 
Cecr6 94047 cat eye syndrome chromosome region, candidate 6 -1.51 
Casq2 12373 calsequestrin 2 -1.52 
Gzma 14938 granzyme A -1.52 
Tmem132c 208213 transmembrane protein 132C -1.53 
Klra3 16634 killer cell lectin-like receptor, subfamily A, member 3 -1.53 
Nxph3 104079 neurexophilin 3 -1.53 
Ppp1r1b 19049 protein phosphatase 1, regulatory (inhibitor) subunit 1B -1.53 
Pdlim4 30794 PDZ and LIM domain 4 -1.53 
Krt23 94179 keratin 23 -1.54 
Muc20 224116 mucin 20 -1.54 
Kcnf1 382571 potassium voltage-gated channel, subfamily F, member 1 -1.54 
S1pr5 94226 sphingosine-1-phosphate receptor 5 -1.54 
Cd79b 15985 CD79B antigen -1.54 
Il1r2 16178 interleukin 1 receptor, type II -1.54 
Padi4 18602 peptidyl arginine deiminase, type IV -1.54 
Iglc3 110787 immunoglobulin lambda constant 3 -1.55 
Ppp1r3c 53412 protein phosphatase 1, regulatory (inhibitor) subunit 3C -1.55 
Cpm 70574 carboxypeptidase M -1.56 
Elovl1 54325 
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, 
yeast)-like 1 -1.56 
Table 4.4 (cont.) 
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Sell 20343 selectin, lymphocyte -1.56 
Cx3cr1 
 
13051 
 
chemokine (C-X3-C motif) receptor 1 
 
-1.57 
 
Selenbp2 20342 selenium binding protein 2 -1.57 
Pax5 18507 paired box 5 -1.59 
Ccna1 12427 cyclin A1 -1.59 
Samd3 268288 sterile alpha motif domain containing 3 -1.59 
Ptger3 19218 prostaglandin E receptor 3 (subtype EP3) -1.59 
Tnc 21923 tenascin C -1.60 
Slfn4 20558 schlafen 4 -1.60 
Ccr9 12769 chemokine (C-C motif) receptor 9 -1.61 
Rspo4 228770 R-spondin 4 -1.61 
Scn3a 20269 sodium channel, voltage-gated, type III, alpha -1.62 
Rasd2 75141 RASD family, member 2 -1.62 
Cftr 12638 cystic fibrosis transmembrane conductance regulator -1.64 
Ighm 16019 immunoglobulin heavy constant mu -1.65 
H2-Eb2 381091 histocompatibility 2, class II antigen E beta2 -1.66 
Hes2 15206 hairy and enhancer of split 2 (Drosophila) -1.66 
Adgre4 52614 adhesion G protein-coupled receptor E4 -1.66 
Clmp 71566 CXADR-like membrane protein -1.66 
Fam196a 627214 family with sequence similarity 196, member A -1.67 
Pgam2 56012 phosphoglycerate mutase 2 -1.68 
Mcidas 622408 
multiciliate differentiation and DNA synthesis associated cell 
cycle protein -1.68 
St6galnac3 20447 
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-
acetylgalactosaminide alpha-2,6-sialyltransferase 3 -1.68 
Abca17 381072 ATP-binding cassette, sub-family A (ABC1), member 17 -1.69 
Fam83a 239463 family with sequence similarity 83, member A -1.69 
Ighd 380797 immunoglobulin heavy constant delta -1.70 
Cd19 12478 CD19 antigen -1.70 
Ly6c2 100041546 lymphocyte antigen 6 complex, locus C2 -1.71 
Cd79a 12518 CD79A antigen (immunoglobulin-associated alpha) -1.72 
Tnfsf9 21950 tumor necrosis factor (ligand) superfamily, member 9 
                                
-1.72 
Table 4.4 (cont.) 
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Spib 272382 Spi-B transcription factor (Spi-1/PU.1 related) -1.73 
Cxcr2 12765 chemokine (C-X-C motif) receptor 2 -1.74 
Blk 12143 B lymphoid kinase -1.74 
Unc80 329178 unc-80 homolog (C. elegans) -1.74 
Cxcr5 12145 chemokine (C-X-C motif) receptor 5 -1.75 
Klk14 317653 kallikrein related-peptidase 14 -1.76 
Ccdc42 276920 coiled-coil domain containing 42 -1.76 
Fcrl1 229499 Fc receptor-like 1 -1.77 
Gpr174 213439 G protein-coupled receptor 174 -1.78 
Gmnc 239789 geminin coiled-coil domain containing -1.78 
Tulp1 22157 tubby like protein 1 -1.79 
Klrg1 50928 killer cell lectin-like receptor subfamily G, member 1 -1.82 
Tnf 21926 tumor necrosis factor -1.82 
Slco4a1 108115 solute carrier organic anion transporter family, member 4a1 -1.83 
Fcer2a 14128 Fc receptor, IgE, low affinity II, alpha polypeptide -1.83 
Retnlg 245195 resistin like gamma -1.83 
Dbp 13170 D site albumin promoter binding protein -1.85 
Iglc2 110786 immunoglobulin lambda constant 2 -1.86 
Ly6d 17068 lymphocyte antigen 6 complex, locus D -1.86 
Mmp9 17395 matrix metallopeptidase 9 -1.91 
Cr2 12902 complement receptor 2 -1.92 
Ms4a1 12482 membrane-spanning 4-domains, subfamily A, member 1 -1.92 
Bank1 242248 B cell scaffold protein with ankyrin repeats 1 -1.95 
Acoxl 74121 acyl-Coenzyme A oxidase-like -1.98 
Cxcl15 20309 chemokine (C-X-C motif) ligand 15 -1.98 
Pbld1 68371 phenazine biosynthesis-like protein domain containing 1 -2.00 
Ifitm6 213002 interferon induced transmembrane protein 6 -2.00 
Ptx3 19288 pentraxin related gene -2.05 
Olfr1342 258708 olfactory receptor 1342 -2.06 
S100a8 20201 S100 calcium binding protein A8 (calgranulin A) -2.14 
S100a9 20202 S100 calcium binding protein A9 (calgranulin B) -2.17 
Tnfrsf13c 72049 tumor necrosis factor receptor superfamily, member 13c -2.30 
Myh13 544791 myosin, heavy polypeptide 13, skeletal muscle -2.30 
Table 4.4 (cont.) 
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Gm4759 209380 GTPase, very large interferon inducible 1 pseudogene -2.72 
Spon2 100689 spondin 2, extracellular matrix protein -2.74 
Igkv19-93 692161 immunoglobulin kappa chain variable 19-93 -2.76 
Nr1d1 217166 nuclear receptor subfamily 1, group D, member 1 -2.81 
Genes included have a FDR raw p-value < 0.05 and log2 Fold Change > 1.5 or < -1.5. 
    
 
 
Table 4.5. List of significant differentially expressed genes in S.2 vs NS.2 
Gene Symbol Entrez ID Gene Name Fold Change 
Cxcr1 227288 chemokine (C-X-C motif) receptor 1  1.89 
Rarb 218772 retinoic acid receptor, beta -1.52 
Hcn1 15165 hyperpolarization-activated, cyclic nucleotide-gated K+ 1 -1.59 
Genes included have a FDR raw p-value < 0.05 and log2 Fold Change > 1.5 or < -1.5. 
 
 
Table 4.6. List of significant differentially expressed genes in S.2 vs S.1 
Gene Symbol Entrez ID Gene Name Fold Change 
Sphkap 77629 SPHK1 interactor, AKAP domain containing  1.84 
Ccr9 12769 chemokine (C-C motif) receptor 9  1.82 
Tnfsf9 21950 tumor necrosis factor (ligand) superfamily, member 9  1.54 
Dcdc5 329482 doublecortin domain containing 5 -1.51 
Malat1 72289 
metastasis associated lung adenocarcinoma transcript 1 (non-
coding RNA) -1.62 
Gdap10 100504486 ganglioside-induced differentiation-associated-protein 10 -1.65 
Abca13 268379 ATP-binding cassette, sub-family A (ABC1), member 13 -1.66 
Tmem245 242474 transmembrane protein 245 -1.72 
Zbtb20 56490 zinc finger and BTB domain containing 20 -2.37 
Genes included have a FDR raw p-value < 0.05 and log2 Fold Change > 1.5 or < -1.5. 
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Figure 4.1. Hierarchical clustering of normalized samples within the Control, Non-
Smoke, and Smoke samples. Complete linkage completed using simple hierarchical clustering 
using Euclidean distances for all samples including control, non-smoke, and smoke groups to 
determine grouping and outliers via branching height. Samples described individually with 
treatment (C, NS, S), tactical choice (1 or 2), followed by specific sample number. 
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Figure 4.2. Principal component analysis of Control, Non-Smoke, and Smoke gene 
expression data. Principal components 1 and 2 are shown with control samples are represented 
by circles (red color). The non-smoke samples are represented by squares (lime color) and the 
smoke samples represented as diamonds (blue color). The numeric 1 and 2 represent interior and 
transitional tactical choice, respectively. 
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Figure 4.3. Heatmaps showing changes in global gene expression of Non-Smoke and 
Smoke samples after interior attack exposure. Heatmap showing changes in global gene 
expression of the non-smoke and smoke treatment groups after live-fire exposure with interior 
tactical choice. Each row represents one gene (within-treatment type one-way ANOVA FDR p-
value < 0.05). Scale is based on standard deviations from the mean expression level across all 
samples with greater expression represented in red and lesser expression by blue relative to the 
mean. Each individual column corresponds to respective treatment group of individual samples.  
C.1 C.2 NS.1 NS.2 S.1 S.2 
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Figure 4.4. Significant over-representation KEGG pathways amongst Smoke treated 
samples. Over-representation testing completed based on purple and black gene sets identified 
from heatmap (Fig. 3) using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. 
Pathways assessed as significant with raw p-values < 0.005. Significance shown in graph 
amongst all related clusters with red scale (-log10) indicating p-value with actual p-values 
printed inside respective boxes and grey boxes show no genes in list mapped to that particular 
pathway. 
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